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ABSTRACT 
Rhythmic auditory stimulation for gait training in persons with 
unilateral transtibial amputation: A Randomized Controlled Trial 
Department of Physical Medicine and Rehabilitation 
Lahunlang Millian Sohliya 
MD Physical Medicine and Rehabilitation 
Dr. Raji Thomas (guide) 
OBJECTIVES 
To compare the time taken for prosthetic training using Rhythmic Auditory Stimulation 
with that of conventional therapy, for unilateral transtibial amputee patients 
To compare the gait parameters in unilateral transtibial amputee patients trained with and 
without Rhythmic Auditory Stimulation 
METHOD OF THE STUDY 
44 patients were enrolled in the study out of which 15 patients dropped out, the most 
common reason being due to ulcers present in the residual limb. A total of 29 patients 
continued on with prosthetic training of which 13 were in the RAS group and 16 in the 
control group. Those in the RAS group received rhythmic beats introduced through MP3 
   
 
xxi 
 
players and earphones during prosthetic training for one hour daily. Conventional 
prosthetic training was carried out for those in the control group for the same duration 
every day. On completion of training as per defined criteria, the outcome measures were 
analysed by a blinded assessor. Primary outcome measures included time to complete 
training, timed up and go (TUG) test and 6MWT while secondary outcome measures 
included gait velocity, gait cadence, step length, stride length, symmetry, stance swing 
ratio, single limb support and physiological cost index (PCI). Kinetic analysis was done in 
9 patients. The outcome measures were statistically analysed by the Independent sample T 
test.   
RESULTS 
1. RAS enhanced prosthetic training decreased time required to complete training (6.08 
hours) in transtibial amputee patients compared to conventional therapy (7.44 hours) 
though the result was not statistically significant. 
2. In the TUG test and 6MWT, patients in the RAS group did better (TUG 11.09 s, 6MWT 
323.37 m) than those in the control group(TUG 13.43, 6MWT 288.96 m). Though no 
statistical significance could be derived, the potential of RAS to improve walking 
endurance was noticed. 
3. Because of external cueing possibly leading to “forced gait”, step length was found to be 
significantly better for those in the control group (p value 0.016 in the amputated limb, 
0.019 in the normal limb). RAS may not be effective in improving step length in transtibial 
amputee patients.  
4. On doing a sub-analysis excluding two patients whose results skewed the data, statistical 
significance was found for the TUG test (p value 0.020) and percentage decrease from 
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regression to 6 minute walk(p value 0.038)  for patients in the RAS group as compared to 
the control group. Most parameters were found to be better in the RAS group.  
5. Patients in the RAS group finished training in a significantly shorter time when they 
used slower frequency beats (p value 0.03). 6MWT of statistical significance (p value 0.01) 
was seen with the use of higher frequency beats. 
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1 INTRODUCTION 
 
The physical loss of a body part can result in significant changes in body structure and 
function, cause loss of self-confidence and hinder social and daily activities. One of the 
major needs of a person who has undergone an amputation is to regain the ability to walk 
again, independently. To achieve this, the individual is given a prosthesis which is by 
definition an artificial substitute for a missing body part. It compensates for the loss of 
body structure and function.  
Training a patient to walk again can be a challenge. An amputee gait differs from a normal 
gait in having less velocity, cadence, stride and step length with associated discrepancy 
between prosthetic and sound leg.(1)Addressing the problem and making a person mobile 
again can bring a dramatic change in the Quality of Life (QoL) of the individual as well as 
of the family members. 
The aesthetic and spiritual qualities of music have always been the base of using music in 
the medical field. It was not until the recent years that the neurophysiology and circuitry of 
pathways leading to the actual effect of music on the human brain and body were studied. 
The knowledge accumulated in the past two decades suggest that music can stimulate 
complex cognitive, affective, and sensorimotor processes in the brain that can be 
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generalized and transferred to non-musical therapeutic applications.(2) Studies in this field 
are still a matter of ongoing research.  
The study of rhythm which is one of the most important elements of music has produced 
insights into musical time processing and temporal information processing in the human 
brain. Rhythmic auditory stimulation (RAS) is believed to be based on the mechanism of 
rhythmic entrainment and priming of auditory pathway. The physiological basis is 
detection of periodicity patterns in amplitude modulation of sound.  Enhancement of gait is 
mediated by an entrainment effect where movement frequency and motor programming 
entrain to rhythm in anticipatory cueing of final movement patterns.   
For metronomes, immediate carry over effects from walking with to walking without cues 
have been reported for walking speed, cadence, stride length and symmetry of gait in 
patients with Cerebrovascular accidents, Parkinson‟s disease and traumatic brain injury. 
This has been extrapolated from the idea that RAS influences the brains‟ oscillator and 
time keeper functions that regulate gait.  Patients achieve a final gait pattern which then 
transfers to walking without external cueing. 
Based on this concept, we introduce the possibility of using rhythmic auditory stimulation 
for prosthetic gait training of amputee patients. Two groups of patients will be studied. 
Both groups will comprise of patients with unilateral transtibial amputation who fall within 
the inclusion criteria.  The study group will receive rhythmic beats through external 
earphones for every session of prosthetic training. The control group will 
undergoprosthetic training as is currently being practised, without the use of rhythmic 
beats. The primary outcome measure will be time taken to complete training (measured in 
hours), time to complete the Timed Up and Go (TUG) test and 6 minute Walk test 
(6MWT). Secondary outcome measures will be temporal gait parameters and energy 
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efficiency which will be assessed at a Human motion analysis lab. These outcome 
measures will help define any statistically significant difference between the two groups. If 
found to be significant, this method of training can be introduced into future prosthetic 
training programmes for amputee patients. 
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2 AIMS AND OBJECTIVES 
A I M :  
To evaluate the usefulness of Rhythmic Auditory Stimulation (RAS) for prosthetic training 
in patients with unilateral transtibial amputation 
 
O B J E C T I V E S :   
 To compare the time taken for prosthetic training using Rhythmic Auditory Stimulation 
with that for conventional therapy for unilateral transtibial amputee patients. 
 To compare the gait parameters in unilateral transtibial amputee patients trained with 
and without Rhythmic Auditory Stimulation 
   
 
5 
 
 
3 REVIEW OF LITERATURE 
3.1 CAUSES AND EPIDEMIOLOGY OF AMPUTATION 
Amputation can be the outcome of unforeseen disasters like trauma and road traffic 
accidents, chronic or acute medical illnesses where the limb cannot be salvaged, natural 
calamities, accidents at the workplace, sports injuries, congenital deficiencies, terrorism 
and war. Incidence varies from country to country. The leading causes of amputation in 
developed countries are artero-occlusive vascular diseases, diabetes and tumours 
accounting for 68% of amputations annually. In developing countries, trauma related 
accidents including motor vehicle, industrial or farming accidents are the leading causes of 
amputations accounting for 30% of new limb amputations.(3) 
 Incidence and Prevalence: The worldwide prevalence of amputation rates is difficult to 
ascertain as many countries do not keep tabulated records of amputation cases.  The 
incidence of amputation increases steeply with ages above 60, the major causes being 
trauma and cancer (4)and is higher in men than in women.(5) 
 Road traffic accidents: The GlobalStatus Report on Road Safety 2013 presents 
information from 182 countries. It indicates that worldwide the total number of road 
accidents leading to death is still at a high of 1.24million per year.  In India, the incidence 
of deaths due to road accidents is 16.8 per 100,000 population(4) and 13.8 non-fatal 
accidents per 100,000. From these figures, it is postulated that road traffic accidents 
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leading to traumatic amputations holds a significant percentage. Apart from road accidents, 
train accidents due to overcrowding also hold a percentage of amputation causes.  
 Diabetes Mellitus:  Currently, 135 million people around the world have diabetes and 
more than 62million (more than 7.1% of the adult population) Indians are affected by it.(6) 
By the year 2030AD, India (the current diabetic capital of the world) is expected to have 
the largest number of diabetic patients surpassing the 92million of China. Diabetes related 
lower extremity amputation rates have been found to be 12.5 to 31.6 times that of persons 
without diabetes.(7)Diabetic foot is one of the common diabetic complications found in 
India.(8) Each year, 40,000 individuals undergo lower limb amputations due to diabetic 
complications.(4)However, it is only second to traumatic accidents as the major cause of 
lower limb amputations in India. In a multi-centric study done in India, the leading cause 
of amputation among diabetic patients was found to be infection. Among those who 
underwent major amputations, more than 50% were below knee amputations and 11.9% 
above knee amputations. Of the total number of amputations, over half of them were of 
toes and rays.(9) 
 In the Western world, peripheral vascular diseases(PVD) with or without diabetes account 
for 80-90% of amputations.(4) In a study done in the Indian population(10) the overall 
prevalence of PVD was found to be considerably lower compared to the western 
population.  
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3.2 SURGICAL PRINCIPLES OF AMPUTATION 
3.2.1 IMPORTANCE OF NUTRITIONAL STATUS AND AMPUTATION LEVEL 
Studies done by Dickhautet.al and Kay et al. reported uneventful healing of amputations in 
15 of 16 patients with normal nutritional parameters whereas 11 of 25 malnourished 
patients had postoperative complications including ulcers. It was concluded that lower 
healing rates and higher postoperative complications will be seen in patients with serum 
albumin levels less than 3.5g/dL and total lymphocyte count of at least 1500 cells/ml.(11) 
Waters et al. studied the energy cost of walking for patients with amputations at different 
levels. On comparing with controls without amputations, they confirmed that the lower the 
level of amputation, the better the performance. It is understood that amputation should be 
performed at the lowest level possible if preservation of function is the chief concern.(12) 
3.2.2 TECHNICAL ASPECTS 
The ideal stump length is between 12.5cm to 17.5cm. As it may vary according to height, 
allowing 2.5cm bone length for every 30cm of height gives a satisfactory measurement. 
The most acceptable length is 15cm distal to the medial tibial articular surface.(13) 
With the modern total contact prosthetic sockets which are being used now, the location of 
the scar is not of major importance as long as the scar does not adhere to the underlying 
bone. This is because an adherent scar causes difficulty in fitting the prosthesis and often 
breaks down after prolonged prosthesis use. Redundant soft tissues or “dog ears” also 
create problems in prosthetic fitting.   
Muscles after resection from their origin are usually stabilized by Myodesis (suturing 
muscle or tendon to bone) or Myoplasty (suturing muscle to periosteum or to fascia of 
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opposing musculature). The preferred method if possible is Myodesis as it provides a 
stronger insertion which in turn maximizes strength and minimizes muscle atrophy, 
maximizes residual limb function and is more effective for preventing contractures. Its use 
in limb ischemia is however contraindicated because of increased risk of wound 
breakdown.(13) 
3.2.3 STAGED AMPUTATIONS 
Staged (two-staged) amputations are done in cases of infection and severe trauma. In such 
cases, debridement or stump preparation in the form of an open “guillotine” amputation is 
the first of at least two operations. This is always followed by secondary closure, re-
amputation, revision or plastic repair.(14,15) 
3.2.4 TECHNIQUES SPECIFIC TO BELOW KNEE AMPUTATIONS 
1. Posterior flap technique - This is the most common technique preferred for 
transtibial amputation. The advantage of this flap is placement of the scar in a non-
weight bearing surface.(16) A study done in 1976 by Mooney V et al. also 
confirmed that this technique offered a significant advantage in healing 
rate.(17)The disadvantage however is the potential for ischemia in the flap area. 
2. Skew technique – This is based on equal anteromedial and posterolateral 
fasciocutaneous flaps. Useful if there is inadequate skin to create a posterior 
flap.(18) 
3. Saggital – In this technique, equal medial and lateral myocutaneous flaps are 
created.(19) 
4. Medial - This technique constructs a long medial and a short lateral flap.(20) 
5. Medial –Fish mouth – This method is based on equal anterior and posterior flaps.  
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3.2.5 COMPLICATIONS 
Complications following amputation include medical complications like cardiac and 
pulmonary conditions and can also be local complications related to the residual limb 
including infection, incessant pain, post-operative pain and others which may need re-
exploration. Some of the most common complications we see according to their frequency 
are stated below: 
 Ulcers – Bony edges which are not rasped or smoothened out can be one of the major 
causes of ulcer complications especially in bony prominences such as anterior aspect of 
tibia for transtibial amputations and lateral aspect of femur for transfemoral 
amputations.(13) Residual limb skin conditions are also another major aspect determining 
the development of ulcers. Levy in 1956 was one of the earliest researchers in this field 
where he emphasized that skin problems (folliculitis, contact dermatitis, stump edema 
syndrome, epidermoid cysts) and stump hygiene should not be overlooked in an amputee 
patient. During weight bearing, the skin is exposed to shear forces which cause repeated 
ulcerations at the stump prosthesis interface. This can be exaggerated with poor nutritional 
status, vascular insufficiency, poor stump hygiene and inadequate pressure relieving points 
on an ill-fitting prosthesis.(21) 
  A study done by Berridge DC etal. on a hundred amputees with ischemia reported that 13 
– 40% patients with pre-operative infections, low nutritional status, advanced age and 
wound hematomas developed infections. There was no significant difference in wound 
sepsis rates of diabetic patients.(22) 
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 Phantom limb pain – It is defined as a burning, aching, electric-type pain on the amputated 
limb. In a questionnaire for 5000 American veterans done in 2005, 78% reported phantom 
pain. Of those receiving treatment only 1% reported any long last benefit.(23) 
 It was reported that 10-20% of patients who had undergone below knee amputation needed 
re-amputation at the femoral level. Diabetic patients were more prone to higher level re-
amputations than on diabetic patients.(24) 
 Neuroma- A neuroma is formed when a nerve has been divided. It becomes painful when it 
is located in an area which exposes it to repeated pressure and trauma. Different methods 
of isolating and burying the nerve are being practiced. Strong tension and crushing should 
be avoided.(13) 
3.3 CHARACTERISTICS OF TRANSTIBIAL RESIDUAL LIMBS 
It is imperative that residual limbs have certain characteristics which make them adaptable 
to transtibial prostheses. The residual limb characteristics, length of residual limb, range of 
motion at the adjacent joint/presence of any contractures or deformities, individuals‟ goals 
and activities, individuals‟ geographic location are some of the important factors needed 
for determining the prosthetic socket fitting and suspension methods.(25) 
Characteristics of the residual limbs include skin condition, volume (edematous changes), 
location and condition of surgical scar. Residual limb length may vary between long (more 
than 80% of the normal limb), medium (50% of the normal limb) or short (less than 30% 
of the normal limb). 
An ideal stump should have the following characteristics: 
 An ideal length and shape 
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 A non-adherent incision scar 
 All bony end margins should be well covered by muscle and skin 
 It should be free from any open wound or infection 
 Neuromas should be absent 
 There should not be any joint contracture or deformity 
 There should be full range of motion at the joint above it 
3.4 TRANSTIBIAL PROSTHESIS 
When lower limb prostheses are prescribed, the following principles should be 
remembered: 
 The mobility needs of the particular patient are met 
 Maximal comfort with no pain caused by the socket on the residual limb. A poorly 
fitting prosthesis with an uncomfortable socket will lead to limited mobility and 
higher chances of rejection of the prosthesis  
 Correct choice of components for achieving maximal independence and functional 
mobility 
 Acceptable cosmetic appearance 
Transtibial prostheses are comprised of the following components:  
 A socket with silicone liner system which maximizes the comfort and minimizes 
chances of ulceration at the area of the residual limb which comes in direct contact 
with it. The patellar tendon bearing (PTB) socket is the most commonly used 
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socket design. Variations of it are the PTB-SC (Supracondylar) and PTB-SCSP 
(Supracondylar Suprapatellar) sockets. They are most useful for patients with short 
residual limbs. Other alternative sockets such as the total surface bearing (TSB) and 
hydrostatic sockets are being increasingly accepted.(26) 
 The suspension system includes straps (most commonly Supracondylar cuff strap), 
prosthetic sleeves, suction and gel liners with locking mechanisms.(27) Sleeve 
suspension consists of elastic sleeves, rubber or neoprene which are pulled up over 
the thigh after donning the prosthesis.(28) Gel liners reduce shear which make them 
the option of choice in residual limbs with compromised skin integrity or those 
with skin grafts. The suction suspension system works through a partial vacuum 
which is created by an air valve present at the bottom of the prosthesis with an air 
tight sleeve.(29) 
 An endoskeletal pylon is most commonly used. It allows further alteration if 
needed after fabrication of the prosthesis. It absorbs shock on impact and helps 
reduce energy expenditure. 
 A suitable prosthetic foot completes the transtibial prosthesis. It can be basic, 
articulated or dynamic response. Solid Ankle Cushion Heel (SACH) foot is the 
most commonly and widely accepted basic prosthetic foot. Articulated prosthetic 
feet come as single axial or multi-axial joints. Dynamic response feet help in push 
off and decrease force of impact of the other foot with the ground.(27) 
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3.5 PROSTHETIC TRAINING IN TRANSTIBIAL AMPUTEE PATIENTS  
“If we all did things we are capable of doing, we would literally astound ourselves.” 
Thomas Alva Edison 
Persons with amputated lower limbs and new prostheses many a time believe that they are 
individually capable of walking without the need of gait training. Though positive attitude 
goes a long way in helping them ambulate, gait training is also necessary to achieve a 
smooth and more importantly safe gait. To achieve this, the steps to be followed are 
broadly divided into: (30) 
1. Weight bearing and balance training – Partial weight bearing 
progressing to full weight bearing, side walking within parallel bars 
with or without support, balance board, obstacle stepping  
2. Specific gait training- Alternate step forward of sound leg and prosthetic 
leg progressing to walking within parallel bars with or without support 
3. Advanced exercises – Walking on an uneven surface, negotiating ramps 
and slopes, running 
4. Functional exercises – Negotiating stairs, independent transfers from 
bed, chair and floor  
Certain factors contribute to the success of prosthetic mobility training. Davies and Datta 
in their study “Mobility outcome following lower limb amputation” stated that chances of 
prosthetic mobility decreased with increasing age.(31) They also stated that almost all 
unilateral transtibial amputees less than 50 years of age attained community mobility 
whereas only 50% of those more than 50 years of age attained community mobility. 
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Another study done on 46 patients with below knee amputations stated that the rate of 
progression with temporary prosthesis was correlated with age and rate of healing.(32) 
3.6 HUMAN WALKING 
Walking is a method of bipedal locomotion involving the use of two legs alternately to 
provide both support and propulsion with at least one foot in contact with the ground at all 
times. Each individual can be distinguished by their gait as it is unique to every person. 
When a problem arises within the body, such as in amputation of a limb, repetition of the 
gait cycle is disturbed. To overcome this, certain techniques are adopted to carry oneself 
during walking. 
Gait cycle and a repetition of gait cycles compose smooth human walking. To better 
understand this, we will look at gait in different sections.  
Phases of gait 
One gait cycle is defined as the initial contact of the foot to successive ipsilateral initial 
contact. Gait cycle is divided into two phases: the stance phase (60%) and swing phase 
(40%). The subdivision in each phase is elaborated in Figure3.1 and Table 3.1 
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FIGURE 3.1 - GAIT CYCLE IN A RIGHT UNILATERAL TRANSTIBIAL AMPUTEE 
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TABLE 3.1 - ACTION OF THE ANKLE, KNEE AND HIP IN DIFFERENT PHASES OF GAIT 
STANCE 
PHASE(60%) 
 SWING PHASE 
(40%) 
 
Initial contact 
(IC) 
(0-10%) 
A: Foot strikes ground. 
Ankle in DF 
K: In extension 
H: 40 ° flexed 
Initial swing 
(ISw) 
(60-80%) 
A: DF 
K: Rapid flexion 
H: Neutral to flexion 
Loading 
response (LR) 
(11%) 
A: Heel rocker 
K: Start flexing 
H: Begins extending 
  
Mid stance 
(MSt) 
(11-30%) 
A: Ankle rocker 
K: Coming to neutral 
H: Controlled extension 
Mid swing (MSw) 
(80-90%) 
A: DF 
K: Extension 
H: Flexion 
Terminal Stance 
(TSt) 
(30-50%) 
A: Forefoot rocker 
K: Full extension 
H: Hyperextension 
  
Pre swing (PSw) 
(50-60%) 
A:PF 
K: Starts flexing 
H: Starts flexing 
Terminal swing 
(TSw) 
(90-100%) 
A:DF to neutral 
K: Extension 
H: Flexion 
 
A-Ankle; K- Knee;  H-Hip;  DF- Dorsi flexion;  TA- Tibialis Anterior;  PF- Plantar flexion 
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Gait stability in stance 
Based on contact of foot with the floor, the gait cycle can also be divided into single limb 
support and double limb support. 
TABLE 3.2 - DESCRIBING SINGLE LIMB SUPPORT AND DOUBLE LIMB SUPPORT 
Single limb support(SLS) Double limb support (DLS) 
The period in which one limb is in contact 
with the floor 
The period in which both feet are in contact 
with the floor 
Occurs once during each cycle Occurs twice during each cycle 
Accounts for 80% of the gait cycle Each DLS accounts for 11% of gait cycle 
Total DLS 20-22% during each cycle 
 
Different parameters of gait  
1. Gait velocity (47 ± 15m/min*)- A measure of ambulation speed calculated as the 
distance walked in a minute 
2. Gait cadence – Number of steps in a period of time, commonly expressed as steps 
per minute 
3. Step length – Distance between the feet in the direction of progression covered 
during one step 
4. Stride length(84 ± 18cm*)–The distance between the same foot in the direction of 
progression during one stride 
5. Stance swing ratio (60:40) – The ratio of 60% stance to 40% swing where the 
stance foot side is in direct contact with the ground and the swing foot side swings 
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through to take the next step. It is affected in gait deviations causing increased 
instability and decreased velocity.  
6. Single limb support (40 ± 5%*)– Measured as the percentage of weight bearing on 
a single lower limb 
7. Symmetry  -  A measure of step lengths comparing the normal and the unaffected 
sides calculated by the formula:  
𝑺𝒕𝒆𝒑 𝒍𝒆𝒏𝒈𝒕𝒉 (𝒖𝒏𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅 𝒍𝒊𝒎𝒃) –  𝑺𝒕𝒆𝒑 𝒍𝒆𝒏𝒈𝒕𝒉 (𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅 𝒍𝒊𝒎𝒃)
𝑺𝒕𝒆𝒑 𝒍𝒆𝒏𝒈𝒕𝒉 (𝒖𝒏𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅 𝒍𝒊𝒎𝒃)
 
EQUATION 3.1 - SYMMETRY 
*Normal values extrapolated from the data of ten 5-15 year olds in a study done in the 
movement analysis laboratory, Rehabilitation Institute, CMC Vellore, 1998. 
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Determinants of gait(Saunders 1953) 
They produce forward progression with the least energy expenditure 
TABLE 3.3 - DESCRIBING THE SIX DETERMINANTS OF GAIT (27) 
1.PELVIC ROTATION Pelvis rotates medially to the swinging leg side, lengthening 
the leg on that side and preventing sudden drop in CoG by a 
4° pelvic rotation during DLS.  
2.PELVIC TILT Pelvis on the swinging side lowers by 4-5° which lowers the 
CoG at midstance 
3.KNEE FLEXION IN 
STANCE 
Knee flexes 15° at heel strike(IC). Reduces the vertical 
elevation of the body at MSt. This lowers the CoG 
minimizing energy expenditure. Also acts as shock absorption 
at the time of IC 
4.ANKLE 
MECHANISMS 
Weight transfer from heel to flat foot associated with 
controlled PF of the foot during first part of stance 
5.KNEE MECHANISMS Knee flexes 30-40° during last part of stance before going into 
extension as ankle goes into PF 
6.LATERAL 
DISPLACEMENT OF 
PELVIS 
Displacement towards stance limb. Reduces the horizontal 
displacement of the CoG 
 
CoG- Centre of Gravity; DLS- Double limb support; IC-Initial contact;  MSt-Midstance;  
DF- Dorsiflexion;  PF- Plantarflexion 
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Energy efficiency  
Energy efficiency is measured by the Physiological Cost Index (PCI). In 1979, MacGregor 
suggested a simple, non-invasive way of measuring physiological cost of walking. It is 
based on the linear relation between heart rate and walking speed to Oxygen consumption. 
It is calculated by the formula:  
𝑷𝑪𝑰 (𝒃𝒆𝒂𝒕𝒔/𝒎)  =
𝑾𝒂𝒍𝒌𝒊𝒏𝒈 𝒉𝒆𝒂𝒓𝒕 𝒓𝒂𝒕𝒆 –  𝑹𝒆𝒔𝒕𝒊𝒏𝒈 𝒉𝒆𝒂𝒓𝒕 𝒓𝒂𝒕𝒆 (𝒃𝒆𝒂𝒕𝒔/𝒎𝒊𝒏)
𝑨𝒗𝒆𝒓𝒂𝒈𝒆 𝒘𝒂𝒍𝒌𝒊𝒏𝒈 𝒔𝒑𝒆𝒆𝒅 (𝒎/𝒎𝒊𝒏)
 
EQUATION 3.2 - PHYSIOLOGICAL COST INDEX 
 
3.7 GAIT ANALYSIS 
The concept of depicting human motion was introduced during the Renaissance period. 
Giovanni Alfonso Borelli a student of Galileo was one of the pioneers in analyzing motion 
while developing his theory of muscle action based on mechanical principles. In 1872, 
Eadweard Muybridge attempted taking a still photograph of a running horse with all four 
feet off the ground. Years later, a sequence of still photographs could be produced. This 
was the beginning of gait analysis.(33) 
The following are the components of gait analysis:(34) 
1. Video gait analysis–Visual analysis is a qualitative study performed to develop 
the initial examination of a patient. In slow motion analysis and frame to frame 
analysis, various measurements can be made. This can yield good descriptive 
information. The limitations are the possibility of human error.  
2. Kinematics–It describes the spatial movement of the body. Data is collected from 
infrared LEDs which are placed over the joints of a patients‟ body.  
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3. Kinetics–It deals with forces which are produced during walking. It follows 
Newton‟s third law where “every reaction has an equal and opposite reaction”. 
This means that the ground reaction force (GRF) is a reaction of the body weight 
and acceleration. The data is collected when the patient steps on a force plate which 
measures the force of the foot exerted on it. 
4. Dynamic electromyography - It is a more discriminating technique which helps 
to define which muscle is in action for a certain movement of the joint.  It is 
measured through surface EMGs which are attached superficially over the skin. 
They detect the electrical signals that activate muscle fibers.  
5. Energy consumption - Energy is consumed during walking and is conserved by 
activating only the muscles which are needed for a certain movement. It is a 
measure of how much energy is spent on a certain activity. It is increased in case of 
abnormalities of gait because of a disturbance in the determinants of gait 
responsible for energy conservation. 
3.8 STUDIES OF GAIT IN TRANSTIBIAL AMPUTEE PATIENTS 
The different parameters of gait in an individual with a lower limb amputation differs from 
that of an able bodied person.(35) International studies comparing the gait of individuals 
with transtibial amputations, have reported decreased cadence, shorter stride and step 
length, wider step width, slower walking speed and longer time to initiate gait.(1) There is 
also asymmetry between the prosthetic limb and sound limb. Step time, step length and 
swing time were longer whereas stride length and stance time were shorter on the 
prosthetic limb compared to the intact limb.(36) 
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Variations in gait according to cause of amputation have also been studied. Gait 
performance of vascular amputees were found to differ from that of traumatic amputees, a 
difference that was not caused by reduced walking speed.(37) The disparity was in the 
difference in push off, where those with vascular causes lacked active forces which were 
present in healthy and traumatic gait. This could be attributed to the effect of the systemic 
disease. 
Studies measuring gait parameters in the Indian population are few.  One such study done 
to quantify the differences between transtibial amputee gait and able bodied gait at 
different walking speeds showed significant reduction (p<0.5) in speed, cadence and  
parameters including single limb support on prosthetic limb and step length. Time during 
double limb support and single limb support on sound limb were augmented (p<0.5). 
However, there did not seem to be any significant effect (p<0.88) on the gait efficiency, 
though a gradual drop of PCI with speed increment was seen, indicating better efficiency at 
higher walking speeds.(38) 
Another Indian based study looked into the effect of residual limb length on gait 
parameters. It was found that amputee patients with longer stump length (54.2%-64.6% of 
the sound limb length) had more efficient gait in terms of less energy consumption, more 
velocity and more cadence in comparison to those with shorter stump lengths.  Gait and 
prosthesis efficiency were also evidently more as there was better skin protection and 
longer lever arm for prosthesis fitting, in those with longer stump lengths.(39) 
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3.9 RHYTHMIC AUDITORY STIMULATION – THE CONCEPT 
“Rhythm must have meaning” – Ezra Pound 
Rhythm, derived from the Greek word Rhythmos, is one of the core elements of any 
musical “language structure”. It generally means “a movement marked by the regulated 
succession of strong and weak elements, or of opposite or different conditions”.(40)  For 
the past few decades, rhythm and music were interpreted from emotional, aesthetic and 
motivational points of view. It was only after studies on neurobiology of rhythm done in 
1967 (Paltsev and Elner), 1976(Rossignol and Melvill) and 1980 (Ermolaeva and Borgest) 
(41) that a neuroscience based understanding of music was established. The rich 
physiological basis of sound and auditory rhythm in priming movement and the 
connectivity between this external sound and the motor areas in the brain were also better 
understood. Subsequently, interesting applications, specifically of the rhythmic structures 
of sound to motor rehabilitation were discovered. 
Auditory rhythm has been found to affect the motor system with hierarchical connections 
at the primary motor cortex,  premotor and supplemental cortices, basal ganglia, 
cerebellum, spinal pattern generators and feedback from the vestibular system.(42) 
Research has shown evidence that sound raises the excitability of spinal motor neurons 
mediated by auditory motor circuitry at the reticulospinal level.(43) This is followed by 
auditory projections into the cerebellum via the pontine nuclei and into striatum of the 
basal ganglia via the inferior colliculus and thalamic projections.(44) The striatum then 
projects to the output source of the basal ganglia - the Globus Pallidus which in turn sends 
the auditory waves to the cortical motor structures such as the supplemental cortices and 
pre motor cortex. Feedback comes to the basal ganglia via auditory association areas, 
influencing basal ganglia function in regard to sequencing and timing.(41) 
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Music and physiological processes (heart rate, temperature, blood pressure) are composed 
on vibrations which occur in a regular, periodic manner and are composed of oscillations. 
Entrainment follows the principle of physics whereby two objects vibrating at similar 
frequencies cause a mutual resonance which causes them to start vibrating at the same 
frequency.(45) Due to the speed and high resolution of time processing in the auditory 
system, external rhythm can be used to entrain body rhythm which in turn causes 
physiological changes in the body.  The human body is also a self-correcting system with 
thermostat-like set point limits of simultaneity between motor rhythm and auditory 
rhythm.(46) Using this concept, certain properties of music have been used to promote 
relaxation by “entraining” body rhythm with the slower, regular external auditory 
rhythm.(47,48) This was seen to be effective in anxiety disorders, patients undergoing 
chemotherapy and operative procedures, burn patients, ICU patients and others in similar 
hospital settings. 
3.10 STUDIES OF RHYTHMIC AUDITORY STIMULATION IN CLINICAL 
SCENARIOS 
Rhythmic auditory stimulation as a rehabilitative measure in clinical practice has been 
introduced only in the recent years. As the clinical scenario of each patient differs from 
another, so also the impact of RAS is found to differ in various situations. A review of few 
studies which have looked into the clinical use and impact of music and rhythm on the 
brain are given below:   
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3.10.1 RAS GAIT TRAINING IN PATIENTS WITH HEMIPARESIS FOLLOWING 
CVA 
A number of studies of the entrainment effect of rhythm on hemiparetic gait have been 
done. One of the earlier studies of rhythmic auditory stimulation for stroke patients was 
done by Thaut et al in 1993 on 10 hemiparetic patients four weeks to two years post stroke. 
After a three week training program, they reported improvement in weight bearing stance 
time on the paretic leg, better stride time and stride length symmetries and overall 
improvement in motor unit recruitment patterns reported through EMG. A smoother gait 
trajectory was mapped due to greater vertical displacement and lesser lateral displacement 
of Centre of Mass (CoM).(49) A six week training program on patients within three weeks 
of stroke confirmed a significant improvement in velocity (164% compared to pre-test) and 
stride length(88% compared to pre-test) on the paretic side but no significant improvement 
in symmetry.(50)  There was also 30% reduction in improvement of gait parameters in 
those with three week training programs as compared to six week training programs which 
indicated that significant gains in early post stroke training can still be made after three 
weeks of intervention.(49) 
On comparing RAS to conventional Neurodevelopmental training (NDT)/Bobath training, 
the gains were seen to be significantly higher in the auditory stimulation group.(51) RAS 
during treadmill facilitated gait training showed that musical motor feedback improved a 
stroke patients gait more than conventional therapy. Stride length increased by 18% versus 
0%, gait symmetry deviation decreased by 58% versus 20%,velocity increased by 20% 
versus 4%.(52) In a study done by Ford et al. (2007) (53) focusing on RAS for the upper 
limb, significant improvement in gait and associated arm swing patterns was reported. 
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Rhythmic auditory stimulation is one of the most widely used  neurologic music therapy 
techniques in Japan and has shown to have beneficial effects in stroke patients with lesions 
in the putamen, cerebellum and thalamus.(49) The comprehensive gait pattern changes 
after RAS training lead us to understand that it does not play just a pacemaker role but 
contributes to motor control hence affecting gait.  
Looking at the broader application of music in this group of patients, Musical Neglect 
Training (MNT) is one of the topics of current interest. Here, patients are made to play 
musical instruments which are spatially arranged according to their neglect or arranged in 
chord progression such that they shift their attention from the attended visual field into the 
neglected field. The line cancellation and flower drawing tests as well as the frequency of 
collision on the side of neglect showed significant changes post intervention.(54) 
Neurologic music therapy now meets the standards of evidence based medicine and is 
recognized by the World Federation of Neurorehabilitation.(55) It can be introduced in 
rehabilitation as a standard method of care.  
3.10.2 RAS GAIT TRAINING IN PATIENTS WITH PARKINSONS DISEASE 
Individuals with Parkinson‟s disease have a gait unique to the illness. Two of the most 
characteristic patterns of this gait are bradykinesia and shuffling stride pattern. They also 
have difficulty in initiating gait and turning (freezing). These gait deficits are often 
resistant to dopaminergic medications. Non pharmacologic approaches for improvement of 
mobility were encouraged. One of the earlier studies was a home based gait training 
program using RAS for persons with Parkinson‟s disease.  There was a significant 
(p<0.05) improvement in their gait velocity by 25%, stride length by 12% and cadence by 
10% more than self-paced subjects who improved their velocity by 7% and no training 
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subjects whosevelocity deteriorated by 7%. Timing of EMG patterns  showed a significant 
(p<0.05) change in the Tibialis Anterior and VastusLateralis muscles.(56) 
3.10.3 CEREBRAL PALSY 
Cerebral Palsy is a group of non-progressive movement syndromes that are characterized 
by motor and postural dysfunction. They result from damage to the developing brain due to 
various causes. In children with Cerebral Palsy, the motor cortex is damaged due to which 
the motor control system is disturbed. When gait pattern is not rhythmic, it is likely that the 
internal time keeper is malfunctioning. RAS is a promising option which helps “organize” 
an individuals‟ gait and improve gait patterns by regulating the motor control system 
through stimulation of the basal ganglia, cerebellum and brain stem.(57) 
One of the earlier studies was done in 1998 where seven CP children were given balance 
and ambulation training using rhythmic auditory stimulation. They were reported to have 
improved velocity, cadence, stride length and symmetry.  
In 2007 another study was done comparing the effectiveness of therapist guided training 
and self-guided training using RAS. The therapist guided training group showed a 
statistically significant difference in stride length, symmetry and velocity.(57) 
In 2011, a study of gait training comparing RAS and neurodevelopmental/Bobath training 
in twenty eight CP children reported significantly increased cadence, walking velocity, 
stride and step lengths with decreased anterior pelvic tilt and hip flexion during walking. 
The neurodevelopmental group improved significantly in internal and external rotation at 
the hip joints.(58) 
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3.10.4 MULTIPLE SCLEROSIS 
Patients with this illness experience difficulty ambulating due to spastic quadriparesis and 
other related lower limb impairments. A study which compared therapy by walking 
exercise to rhythm in 10 randomly allocated patients showed improvement in gait 
parameters including stride and step lengths, cadence and velocity in the group with music 
intervention.(59)This was attributed to the fact that entrainment of beats can still occur 
even when areas of auditory motor regulation such as cerebellum are damaged. This is 
because rhythm activates different areas of the central nervous system.  
No other completed studies using rhythm for ambulation training in this group of patients 
were found in literature. 
3.10.5 SPEECH AND LANGUAGE REHABILITATION 
The term Melodic Intonation Therapy (MIT) was first coined in 1973 by Sparks, Helm and 
Albert.(60) It was a method of communication developed for rehabilitation of stroke 
patients with aphasia and other language disorders. It was based on the hypothesis that the 
increased use of right hemispheric dominance for the melodic aspect of speech increases 
the role of that hemisphere in inter-hemispheric control of language, decreasing the 
language dominance of the damaged left hemisphere.(61) To do this, the rhythm, stress, 
prosody and contours of normal speech are transposed to melodic intonation patterns. 
Researches which followed came up with different explanations for the improvement in 
speech post MIT. Evidence suggests that music may activate areas in the brain differently 
than speech or other stimuli do. Music enhances the way the systems work together. It 
activates both hemispheres of the brain-the right more than the left.(62)In 1996, Belin etal. 
in a study on seven non fluent aphasic patients, measured changes of cerebral blood flow in 
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the brain during speech with and without MIT using positron emission tomography (PET). 
Without MIT, the right hemispheric regions were activated homotopic to that in a normal 
subject while the left hemisphere remained deactivated. However on repeating words with 
MIT, reactivation of Broca‟s area and the left prefrontal cortex was seen. Singing which is 
a function of the right hemisphere helps people produce speech by bypassing the damaged 
left hemisphere.(63)Hence it was concluded that music intonation played a major role in 
reactivation of the injured parts of the brain. The incredible plasticity potential of the brain 
was also noted. 
In 2011, a completely different outlook on the relation between speech and melodic 
intonation through singing was introduced by Stahl et al. They proposed the idea that 
articulation may be modulated by visual or auditory rhythmic cues and that rhythm may be 
the neglected crucial element which was in fact decisive for speech production. Subcortical 
areas specifically the basal ganglia are suggested to mediate rhythmic segmentation in 
producing and perceiving speech. Subcortical lesions can cause loss in rhythmicity of 
speech. They concluded that such a group of patients would particularly benefit from 
rhythmic auditory stimulation of speech and that rhythmic hand tapping could have a 
profound impact on speech production in aphasics.(64) 
 In 2013, they confirmed the critical role of rhythmic pacing and formulaic language in 
MIT and concluded that standard therapy may engage in left perilesional brain regions 
while training of formulaic phrases which is known to be supported by right corticostriatal 
areas may open new ways of tapping into the right hemispheric language resources even 
without singing.(65) 
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3.10.6 INCOMPLETE SPINAL CORD INJURED PATIENTS 
A pilot study was done on seventeen patients with incomplete spinal cord injuries having a 
mean age of 41years and 5.88 years post injury. No changes in gait parameters were 
statistically significant. At normal tempo, persons with cervical injuries improved in 
cadence and those with thoracic injuries improved in velocity and stride length.(66) 
3.10.7 OTHER GROUPS 
In certain groups of patients such as in critically ill patients in the ICUs and those with 
traumatic brain injuries, music was seen to be more effective for its aesthetic causes. 
Critically ill patients – A majority of critically ill patients receiving mechanical 
ventilation survive with traumatic experiences from the ICU. Patient comfort, pain, 
anxiety, sleep deprivation, depression were some of the ICU symptoms studied. It was 
found that anxiety was alleviated by 36% in a study done on 373 ICU patients.(67) This 
was measured on a 100 point visual analog scale. Sedation intensity and frequency 
(measured by the change in dose of sedatives given) was also seen to be significantly less 
in the group who received music therapy.  
Traumatic brain injury patients–“Neurologic Music therapy” (NMT) has been found 
to be effective in improving executive functions, decreasing anxiety and depression, 
improving emotion and mood in those with traumatic brain injury.(68)A few studies 
reporting the use of rhythmic auditory stimulation as a technique of NMT were found. 
Here, patients with debilitating and gross motor deficiencies after TBI were trained to 
walk. A significant improvement was seen in cadence, velocity and stride length of 7 
patients who had undergone ambulation training with RAS.(69) Another study done on 8 
patients with TBI reported a significant increase by 51% in mean velocity with significant 
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improvements also in stride length(29%) and cadence (16%) and a non-significant 
improvement (12%) in stride symmetry. 
3.11 JUSTIFICATION FOR THE STUDY 
The current protocol being followed in our institute includes a two week prosthetic training 
program for ambulation, sensory motor function and complete independence in all 
activities of daily living. Rhythmic Auditory Stimulation has been researched in patients 
with stroke and has been found to be more effective for rehabilitation than 
neurodevelopmental therapy/Bobath therapy.(51) Different studies have also been done on 
Parkinson‟s Disease,(56) Cerebral Palsy(57) and Multiple Sclerosis,(59) all of which have 
shown positive results. In these studies, acoustic cueing has been used to improve 
pathological gait patterns. In stroke patients, the timing symmetry inherent in the rhythmic 
signal may have served as an efficient cue for the patient to achieve a higher degree of 
stride symmetry. In Parkinson‟s disease, rhythm may have acted as an external timekeeper, 
to which the step cadence became synchronized, helping the patient to stabilize internal 
time keeping and rhythm formation, giving him a steady gait. 
 
 This study is a trial to determine if prosthetic training period for amputee patients can be 
decreased and if gait parameters can be improved by following the same theory supporting 
the previous studies done on patients with Stroke, Parkinson‟s disease, Multiple sclerosis 
and Cerebral palsy.  
 The purpose of this study as we have stated is to determine if this method of training can 
decrease the period of prosthetic training and also improve gait parameters. Decreasing the 
prosthetic training period would be cost effective for the patients and their families. It does 
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not restrict other therapy which can occur simultaneously. As the only intervention will be 
rhythmic beats which will be introduced by external sources like earphones, there are no 
expected side effects or adverse problems we foresee. 
Since no similar study has been found on Amputee patients, this can be a useful tool for 
future prosthetic training in amputee patients. 
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4 METHODOLOGY 
4.1 STUDY DESIGN 
 Randomized control trial, single blinded 
4.2 SETTINGS AND LOCATION WHERE THE STUDY WAS CONDUCTED  
 Department of Physical Medicine and Rehabilitation, Christian Medical College, 
Vellore 
 Patients were recruited from the Amputee clinic held weekly in the outpatient section 
department. Those who satisfied the inclusion criteria were explained about the study and 
informed consent in their own language was obtained from those who were willing to 
participate. 
After randomized allocation into the two groups, the concerned physiotherapistsand 
occupational therapists started prosthetic training in the PT and OT sections respectively.  
The therapists assessed the endurance of walking and level of independence achieved by 
the patient. Following training, those patients who achieved the predefined criteria for 
independence were then finally evaluated in the Motion Analysis Lab at the 
Rehabilitation Institute of the hospital. The outcome measures such as Timed Up and 
Go, 6 minute Walk Test and analysis for the temporal gait parameters were completed in 
the lab. 
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4.3 ETHICS COMMITTEE APPROVAL 
 Approval for the study was obtained from the Institutional Review Board (Annexure 1)  
 The consent format was submitted in four different languages as expected in the population 
group (English language version in Annexure 2) 
4.4 PARTICIPANTS 
a. Inclusion criteria 
 Unilateral transtibial amputee patients secondary to traumatic, vascular, diabetic and other 
causes who are ready for prosthetic training  
 BMI less than 30 
 Age between 18-70 years 
 First time users of prosthesis 
 Duration of amputation less than 5 years 
 Patients with no deformities or contractures on the amputated or normal side 
b. Exclusion criteria 
 Patients with neurological deficits other than peripheral neuropathy 
 Short residual limb, stump length < 9cm 
 Patients with uncorrected auditory/visual impairment 
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 Patients with amputation of any other limb limiting prosthetic training 
 Any other condition that limits mobility like fractures, cognitive impairment, Osteoarthritis  
knee  
4.5 SAMPLE SIZE 
32 unilateral transtibial amputee patients (16 in each arm) between the ages of 18-70 years 
were targeted for selection from the Amputee Clinic held in the PMR department.  
METHOD OF SAMPLE SIZE CALCULATION: 
Mean no. of days for prosthetic training using conventional methods (µ1)= 14days 
Mean no. of days expected for prosthetic training using RAS (µ2)= 10days 
SD = 4days 
 
 
 
Each arm n= 16 
Sample Size = 32 
EQUATION 4.1 - SAMPLE SIZE CALCULATION 
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4.6 RANDOMIZATION 
4.6.1 METHOD OF ALLOCATION CONCEALMENT 
Serially labelled opaque envelopes concealed randomised allocation 
4.6.2 METHOD OF RANDOMISATION 
Randomization was done using computer generated uniform distribution random numbers. 
A block size of 4 was used. 
4.6.3 BLINDING 
Patient could not be blinded as he would be aware of the rhythmic beats/intervention given 
to him. However the outcome assessor was blinded. 
4.7 IMPLEMENTATION 
After an initial evaluation based on the inclusion/exclusion criteria in the Amputee Clinic, 
individuals who satisfied the inclusion criteria were explained about the study in their own 
language and a written informed consent was obtained.  All of them had completed pre-
prosthetic training and had transtibial prosthesis fabricated before inclusion into the 
study.The sequence of randomisation was computer generated and allocation was 
concealed using opaque envelopes. Participants were given the sealed opaque envelopes in 
their sequence and after revealing the allocated group to the patient and therapist, they 
were started on prosthetic training as an outpatient. 
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4.8 INTERVENTION 
Participants were allocated into two groups, one group receiving conventional prosthetic 
training (Control group), and the other group receiving the same training with additional 
rhythmic auditory stimulation (RAS group). Both groups were given prosthetic training 
and the training was considered to be completed when they attained the following criteria: 
  A walking endurance of >250m irrespective of the cause of amputation as is currently 
being followed. This was inclusive of ambulation with a cane or quadripod.  
 Independent transfers, activities of daily living (ADL), bus climbing, step and ramp 
negotiation according to the Rivermead Mobility Index (Annexure 4) 
4.8.1 INTERVENTION GROUP 
Musical cueing and rhythmic entrainment were believed to be the main properties of music 
effective for this group of patients. For this reason, rhythm in the form of beats was used 
and not music.  
The amputee patients in the RAS group were given training enhanced using rhythm.  The 
beats were made on Acoustica Beatcraft a drum machine software program on the internet. 
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FIGURE 4.1 - ACOUSTICA BEATCRAFT SOFTWARE 
The frequency of the beats ranged from 25 bpm - 120 bpm (beats per minute). These beats 
were delivered to the patient using mp3 players with two pairs of earphones attached to a 
splitter, one for the patient and the other for the therapist. Frequency was increased, 
decreased or retained according to the patients‟ abilities and compliance to follow them. In 
the last fifteen minutes of every hour of therapy, the earphones were withdrawn and the 
training consisted of no beats so as to accustom the patient to the normal gait pattern 
without dependence on rhythm.  
Each days‟session consisted of one hour in Physiotherapy for gait training, one hour in 
Occupational therapy for balance training and adaptation techniques to daily living. Each 
therapist had a one on one session with the patient recruited under him/her.  
Each patient started with side to side shifting within the parallel bars and progressed to 
walking outside the bars with or without support depending on their degree of 
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improvement and compliance. At every consecutive session, they directly resumed therapy 
from where they left off in the previous session.  
4.8.2 CONTROL GROUP 
This group received the same therapy without rhythm and had daily one hour of therapy 
each in Physiotherapy and Occupational therapy. They also had a pair of headphones 
without including music, beats or rhythm. This was an attempt of blinding other enrolled 
patients who may be undergoing training in the gym during the same time.  
4.9 OUTCOME MEASURES 
Outcome was analysed once the prosthetic training was completed according to the criteria 
mentioned above. All the outcome measures were assessed without the use of rhythm.  
4.9.1 PRIMARY OUTCOME MEASURES 
 Number of hours to complete training 
Only the number of hours spent on prosthetic training was included. The time lost due to 
development of pressure sores or for socket modification was not included. 
 Timed up and go test (TUG)  
It is a reliable instrument with adequate concurrent validity to measure the physical 
mobility of patients with an amputation of the lower extremity(70) 
After one practice trial which was not timed, the patient‟s level of functional mobility was 
assessed by the length of time he took to stand up from a chair (44-47cm seating 
height),(71) walk 3meters (10ft), walk back and sit down on the same chair. This was 
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assessed by the gait analyst who was blinded to the intervention. It was done at the Motion 
analysis lab in the Rehabilitation Campus.  
In a study done by Dite et al 2007,(72) the cut off for increased risk of falls in patients with 
lower extremity unilateral amputations was 19seconds (sensitivity 85%; specificity 74%).  
In community dwelling adults,(73) the cut off score was 13.5seconds (sensitivity 87%, 
specificity 87%). 
 6 minute walk test (6MWT)  
This is a useful measure of functional capacity in transtibial amputees. It is a reliable test 
which challenges an amputee's functional capacity, balance, and postural control abilities, 
as required in community ambulation.(74) The patients‟ walking endurance at a self-
selected walking pace in 6minutes was calculated. This test was also completed by the gait 
analyst.   
A study was done under the Department of Pulmonary Medicine; CMC Vellore by D.J 
Christopher et al.2005-2006 (unpublished) which measured the predicted value of the 
6MWT in a healthy South Indian population. The predicted value was calculated using a 
regression equationwhichis as follows: 
(7.57 x height) - (5.02 x age) - (1.76 x weight) - 309 for males 
(2.11 x height) - (5.78 x age) - (2.29 x weight) + 667 for females 
EQUATION 4.2 - REGRESSION EQUATION FOR 6MWT 
C. Robinett et al. in their study (75) stated that the distance an individual must ambulate in 
order to be functionally independent in their community was about 132m to 342m. 
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4.9.2 SECONDARY OUTCOME MEASURES 
Data was collected using observational and instrumental gait analysis.  
4.9.2.1 VIDEO GAIT ANALYSIS 
Patients who completed prosthetic training and who could fulfil the criteria mentioned 
were made to ambulate at a self-selected speed on a 22ft walk way in the motion analysis 
lab. Videos from anterior, posterior and both lateral views were taken. They were seen 
with software „Video NAS‟ which was written in Visual Basic. This software could slow 
down the videos allowing a frame by frame observation and comparison of frames.  
4.9.2.2 KINEMATICS 
For kinematic data collection, light emitting diodes (LEDs) were attached to the bony 
prominences of the normal limb and the corresponding joints of the prosthesis of the 
amputated limb. The Phase Space apparatus automatically recorded the movement with the 
help of eight infrared cameras which displayed the output as 3D moving stick figures on a 
monitor. Using the Position Reference Structure (PRS), the position of the cameras in the 
room was defined from a fixed point in the room.  
The following temporal gait parameters were measured. : 
1. Gait velocity (m/min, m/sec) – This was a measure of the speed at which the 
patient was able to walk.  
2. Gait cadence (steps/min) – Measured as the number of steps taken in a minute 
3. Step length (cm)–Measured as the distance covered between the initial contact of 
one foot to the initial contact of the alternate foot 
4. Stride length (cm)–Measured as the distance between heel strike of one foot to 
heel strike of the same foot  
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5. Stance swing ratio(%)–Measured from observational video analysis in the 
following way:  
ST/a : SW/a  =  ST/a x 100 : SW/a x 100 
WhereST= No. of frames for stance; SW =No. of frames for swing; a= No. of frames for 
onegait cycle 
EQUATION 4.3 - STANCE SWING RATIO 
 
6. Single limb support – Measured as the percentage of weight bearing on a single 
lower limb (both normal and amputated side).  
7. Symmetry-  Calculated by the formula:  
𝑆𝑡𝑒𝑝 𝑙𝑒𝑛𝑔𝑡𝑕 (𝑢𝑛𝑎𝑓𝑓𝑒𝑐𝑡𝑒𝑑 𝑙𝑖𝑚𝑏) –  𝑆𝑡𝑒𝑝 𝑙𝑒𝑛𝑔𝑡𝑕 (𝑎𝑓𝑓𝑒𝑐𝑡𝑒𝑑 𝑙𝑖𝑚𝑏)
𝑆𝑡𝑒𝑝 𝑙𝑒𝑛𝑔𝑡𝑕 (𝑢𝑛𝑎𝑓𝑓𝑒𝑐𝑡𝑒𝑑 𝑙𝑖𝑚𝑏)
 
 
 
4.9.2.3 KINETICS 
For kinetic data collection, recordings were made from a force plate (Kistler) 
camouflaged in the middle of the walkway. Using this, ground reaction forces (GRF) 
were measured. 
The following parameters were measured (all in %):  
 Vertical force 
 Medial force 
 Lateral force 
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 Forward force 
 Backward force  
4.9.2.4 ENERGY EFFICIENCY 
Physiological Cost Index (PCI) was calculated by the formula:  
𝑃𝐶𝐼 (𝑏𝑒𝑎𝑡𝑠/𝑚)  =
𝑊𝑎𝑙𝑘𝑖𝑛𝑔 𝑕𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒 –  𝑅𝑒𝑠𝑡𝑖𝑛𝑔 𝑕𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒 (𝑏𝑒𝑎𝑡𝑠/𝑚𝑖𝑛)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑤𝑎𝑙𝑘𝑖𝑛𝑔 𝑠𝑝𝑒𝑒𝑑 (𝑚/𝑚𝑖𝑛)
 
 
All the secondary outcomes were measured by the gait analyst in the motion analysis lab 
who was blinded to the study and was unaware of the group the patient was in.  
OBSERVATIONAL GAIT ANALYSIS 
 
FIGURE 4.2 - RIGHT LATERAL VIEW SHOWING INITIAL CONTACT ON THE AMPUTATED SIDE 
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FIGURE 4.3 - LEFT LATERAL VIEW SHOWING INITIAL SWING ON AMPUTATED SIDE 
 
 
FIGURE 4.4 - ANTERIOR VIEW DURING SINGLE LIMB SUPPORT ON AMPUTATED SIDE 
 
   
 
45 
 
 
FIGURE 4.5 - POSTERIOR VIEW DURING DOUBLE LIMB SUPPORT 
 
 
INSTRUMENTAL GAIT ANALYSIS 
 
FIGURE 4.6 - LED PLACEMENTS OVER LATERAL MALLEOLUS, BASE OF HEEL AND BASE OF 
LITTLE TOE ON LEFT TRANSTIBIAL PROSTHESIS 
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FIGURE 4.7 - LED PLACEMENTS OVER KNEE REGION ABOVE THE PROSTHESIS 
 
FIGURE 4.8 - LED PLACEMENTS OVER GREATER TROCHANTER 
 
FIGURE 4.9 - PATIENT WALKING DURING INSTRUMENTAL GAIT ANALYSIS 
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4.10 STATISTICAL ANALYSIS 
All comparisons between the groups were analyzed using the independent t-test. This test 
was chosen for significance with 2 tails and equal variance. To declare a test statistically 
significant, a level of 5% was used. The statistical software used for analysis was SPSS 
version 20. 
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5 RESULTS 
44patients who satisfied the selection criteria were randomly allocated into the intervention 
and control groups with 24 patients in the intervention group and 20 patients inthe control 
group. 
1 patient in each arm did not come for training. 6 patients from the intervention arm and 3 
patients from the control group dropped out from the study as they could not achieve the 
pre-defined criteria required to complete training due to the development of ulcers. In 
addition 4 patients in the intervention arm discontinued training due to unknown reasons. 
Outcome measurement and statistical analysis could hence be done in only 29 patients, 13 
in the RAS group and 16 in the control group. 
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CONSORT  
 
FIGURE 5.1 - CONSORT 
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TABLE 5.1 - SHOWING DEMOGRAPHIC DATA OF THE PATIENTS  
 RAS group Control group 
Mean age (years) 46 (Range 18-65) 45 (Range 18-65) 
Side of amputation (no.)   
Right 8 6 
Left 5 10 
Cause of amputation (no.)   
Diabetes Mellitus 3 6 
RTA 8 4 
Malignancies 1 1 
Others 1 5 
Gender (no.)   
Male 13 13 
Females 0 3 
Mean Height (cm) 169 (Range 161-180) 172 (Range 152-190) 
Mean weight (kg) 62 (Range 40-80) 60 (Range 58-93.5) 
Basal Metabolic Index 
(kg/m2) 
22 (Range 15.06-28.55) 20 (Range 15.67-29.60) 
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5.1 SIDE OF AMPUTATION 
The study included 29 participants who were unilateral transtibial amputee patients. There 
were 8 right transtibial and 5 left transtibial amputees in the intervention arm, 6 right 
transtibial and 10 left transtibial amputees in the control arm 
 
FIGURE 5.2 - SIDE OF AMPUTATION 
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5.2 ETIOLOGY OF AMPUTATION 
The most common cause for amputation found among our group of patients was road 
traffic accidents comprising of 41.38% of the causes. Second to traumatic accidents were 
diabetic foot due to uncontrolled Diabetes Mellitus accounting for 31.04% of the 
patients.Those having malignancies comprised of 6.90% and those due to other causes 
including infection, vascular causes, peripheral arterial occlusive disease (PAOD), blast 
injury and necrotizing fasciitis comprised a total percentage of 20.69% 
 
FIGURE 5.3 - ETIOLOGY OF AMPUTATION 
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5.3 AGE 
The mean age was 46years for the intervention group and 45 years for the control group.  
The numberofpatients in each age range is tabulated below. 
 
TABLE 5.2 - DISTRIBUTION OF AGE  
AGE (yrs) RAS Control Total 
Mean age(18-70) 46 45 45 
<30 3 (10.34%) 3 (10.34%) 6 (20.69%) 
30-50 3 (10.34%) 6 (20.69%) 9 (31.03%) 
51-70 7 (24.14%) 7 (24.14%) 14 (48.28%) 
 
The majority of the patients in our study group were above 51 years of age. The 
distribution of etiology to age is given in Table 5.3 
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TABLE 5.3 - DISTRIBUTION OF ETIOLOGY TO AGE  
ETIOLOGY RAS Control Total 
Diabetes Mellitus 3 (10.34%) 6 (20.69%) 9 (31.03%) 
<30 years 0 0 0 
30-50 years 1 3 4 
>50 years 2 3 5 
    
RTA 8 (27.59%) 4 (13.79%) 12 (41.38%) 
<30 years 2 2 4 
30-50 years 2 2 4 
>50 years 4 0 4 
    
Malignancy 1 (3.45%) 1 (3.45%) 2 (6.90%) 
<30 years 1 1 2 
30-50 years 0 0 0 
Above 50 years 0 0 0 
    
Others 1 (3.45%) 5 (17.24%) 6 (20.69%) 
<30 years 0 0 0 
30-50 years 0 1 1 
Above 50 years 1 4 5 
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5.4 GENDER 
The RAS group included 13 males (100%) and had no female patients. The control 
groupincluded13males (81.25 %) and 3 females (18.75 %). 
5.5 BMI 
The mean height and mean weight of the participants in the intervention arm was 169cm 
and 62kg respectively. 
The mean height and mean weight of the participants in the control arm was 172 cm and 
60kg respectively. 
 
FIGURE 5.4 - AVERAGE HEIGHT AND WEIGHT DISTRIBUTION 
The average BMI for the participants in the intervention arm was 22 (within normal range) 
The average BMI for the participants in the control arm was 20 (within normal range) 
The majority of patients were within normal weight distribution (BMI 18.5 – 22.9) 
 Distribution of BMI in our group of patients is seen in table 5.4 
 
169172
Average Height
RAS Control
6260
Average Weight
RAS Control
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TABLE 5.4 - DISTRIBUTION OF BMI 
BMI  RAS Control Total 
Below 18.5 3 (10.34%) 7 (24.14%) 10 (34.48%) 
18.5-22.9 5 (17.24%) 6 (20.69%) 11 (37.93%) 
23-24.9 1 (3.45%) 1 (3.45%) 2 (6.9%) 
 
5.6 SURGICAL METHODS 
Two surgical methods were followed for management of the amputated limb: 
Primary closure – Primary closure by posterior myocutaneous flap was done for 
13patients 
Secondary closure – Guillotine amputation and secondary closure was done for 
12patients 
4 patients did not have any surgical details available.  
TABLE 5.5 - SURGICAL METHODS  
Surgery performed  RAS Control Total 
Primary closure by posterior flap 5 (17.24%) 8 (27.59%) 13 (44.83%) 
Guillotine and Secondary closure 6 (20.69%) 6 (20.69%) 12 (41.38%) 
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5.7 PRIMARY OUTCOME MEASURES 
5.7.1 TIME TO COMPLETE THERAPY 
The patients in the RAS/intervention group took a lesser mean time of 6.08 hours to 
complete training compared to those in the control group who took 7.44 hours. This 
difference was not statistically significant (p value 0.159) 
 
FIGURE 5.5 - NUMBER OF HOURS TAKEN TO COMPLETE TRAINING IN RAS AND CONTROL 
GROUPS 
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The period of training based on age distribution and etiology are mentioned in table 5.6 
and figure 5.6 
 
TABLE 5.6 - CORRELATION OF THE NUMBER OF HOURS TO COMPLETE TRAINING WITH AGE 
AND ETIOLOGY IN RAS AND CONTROL GROUPS 
No. of hours for gait training (hrs) 
 
 
RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p value 
Averagehrs 6.08 ± 2.18 [4.76, 7.39] 7.44 ± 2.76 [5.97, 8.91] 0.159 
Age    
<30yrs 5 ± 2.30 [3.61, 6.39] 5 ± 2.50 [4.00, 6.66] 0.722 
30-50yrs 7 ±1.73 [5.95, 8.05] 8 ± 3.62 [5.57, 9.43] 0.831 
51-70yrs 6 ± 2.27 [4.77, 7.51] 
 
8 ± 2.06 [7.19, 9.38] 0.089 
Etiology    
Diabetes Mellitus 6.67 ± 2.08 [5.41, 7.93] 7.5 ± 3.15 [5.82, 9.18] 0.695 
RTA 5.5 ± 2.39 [4.06, 6.95] 8.5 ± 3.87 [6.44, 10.56] 0.124 
Malignancy 8 4 N/A 
Others 7 [5.83, 8.17] 7.2 ± 3.61 [5.28, 9.12] 0.084 
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FIGURE 5.6 - RELATION OF TIME TO COMPLETE TRAINING WITH AGE AND ETIOLOGY 
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The average time for patients to begin prosthetic training was found to be 7 months in the 
intervention group and 8months in the control group. The period of training based on 
duration of amputation is given in table 5.7 
 
TABLE 5.7 - RELATION BETWEEN TIME TO COMPLETE TRAINING AND DURATION OF 
AMPUTATION 
 RAS CONTROL 
Duration of amputation below 6 months (no.) 5 7 
Average hours to complete therapy (hours) 6.2 6.86 
Duration of amputation between 6 months to 1 year (no.) 7 6 
Average hours to complete therapy (hours) 6.57 7.67 
Duration of amputation more than 1 year (no.) 1 3 
Average hours to complete therapy (hours) 2 8.33 
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5.7.2 TIMED UP AND GO (TUG TEST) 
Patients in the intervention arm completed the TUG test at a shorter average time of 
11.09seconds than those in the control arm who completed it in an average time of 
13.43seconds. This difference was not statistically significant (p value 0.061).  
 
FIGURE 5.7 - TUG TEST IN RAS AND CONTROL GROUPS 
Two patients with malignancy leading to amputation (1 in each group) caused significant 
skewing of data. On sub-analysis of TUG test excluding the skewed data, statistical 
significance was seen between the two groups (p value 0.020) 
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TABLE 5.8 - TUG TEST EXCLUDING SKEWED VALUES 
 RAS 
Mean ± SD 
Control 
Mean ± SD 
p value 
TUG (s) 10.60 ± 1.97 13.64 ± 3.83 0.020* 
 
*p value<0.05 is considered statistically significant 
 
The correlation of TUG test with age and etiology in the two groups is shown in Table 5.9 
and Figure 5.8 
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TABLE 5.9 - CORRELATION OF THE TUG TEST WITH AGE AND ETIOLOGY IN THE RAS AND 
CONTROL GROUPS 
 TIMED UP AND GO (secs)  
Age RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p 
value 
Average 11.09 ± 2.59 [9.53, 12.66] 13.43 ±3.74 [11.41, 15.46] 0.069 
Age    
<30years 11.12 ± 5.01 [8.10, 14.15] 14.23 ± 7.02 [10.49, 17.97] 0.570 
30-50 11.23 ±2.15 [9.93, 12.53] 12.09 ±4.98 [9.44, 14.75] 0.576 
51-70 11.02 ± 1.66 [10.01, 12.02] 14.24 ± 3.91 [12.16, 16.33] 0.068 
Etiology    
Diabetes Mellitus 10.33 ± 1.50[9.43, 11.24] 13.67 ±2.74 [12.38, 15.30] 0.083 
RTA 10.38 ±2.07 [0.13, 11.82] 13.50 ±5.69 [10.37, 16.38] 0.218 
Malignancy 17 10 N/A 
Others 12.0 [10.34, 14.50] 13.60 ±4.04 [9.79, 17.42] 0.087 
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FIGURE 5.8 - RELATION OF TIMED UP AND GO TEST WITH AGE AND ETIOLOGY 
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5.7.3 6 MINUTE WALK TEST 
The average distance covered during the 6MWT for patients in the intervention arm 
was323.37m andthis was more than that in the control arm which was 288.96 m. This 
difference was not statistically significant (p value 0.390). With exclusion of the two 
skewed values, the p value was 0.081. 
Table for 6MWT with distribution of age and etiology is given below: 
TABLE 5.10 - CORRELATION OF THE 6 MINUTE WALK TEST WITH AGE AND ETIOLOGY IN THE 
RAS AND CONTROL GROUPS 
 6 MINUTE WALK TEST  
 RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p 
value 
Average 323.37 ± 115.84 [393.37, 
253.37] 
288.96 ± 96.25 [340.25, 
237.68] 
0.390 
Age    
<30years 364.17 ± 169.53 [466.62, 
261.72] 
312.09 ± 148.17 [391.04, 
233.14] 
0.934 
30-50 401.17 ± 80.48 [449.80, 
352.53] 
325.43 ± 92.27 [374.59, 
276.26] 
0.268 
51-70 272.54 ± 61.51 [309.73, 
235.36] 
247.80 ± 93.66 [297.69, 
197.91] 
0.57 
Etiology    
Diabetes 
Mellitus 
373.33 ± 124.68 [448.68, 
297.99] 
 
246.17 ± 75.29 [286.13, 
205.92] 
0.092 
RTA 339.63 ± 104.37 [402.76, 
276.61] 
346.50 ± 114.90 [407.73, 
285.40] 
0.919 
Malignancy 135 392 N/A 
Others 232 [270.63, 192.93] 273.80 ± 93.55 [351.44, 
196.16] 
0.081 
 
   
 
66 
 
 
FIGURE 5.9 - 6MWT TEST IN RAS AND CONTROL GROUPS 
 
 
FIGURE 5.10 - RELATION OF THE 6MWT WITH AGE AND ETIOLOGY OF RAS AND CONTROL 
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5.8 SECONDARY OUTCOME MEASURES 
5.8.1 GAIT VELOCITY 
The average gait velocity for patients in the intervention group was 45.31m/sec, for those 
in the control group was 44.44m/sec. The difference in average velocities between the two 
groups was not statistically significant (p value 0.881) 
Gait velocity in relation to age and etiologyis given in Table 5.11 and Figure 5.11 below: 
TABLE 5.11 - CORRELATION OF GAIT VELOCITY WITH AGE AND ETIOLOGY IN THE RAS AND 
CONTROL GROUPS 
 GAIT VELOCITY (m/sec)  
 RAS 
Mean ± SD, 95% CI 
CONTROL 
Mean ± SD, 95% CI 
p value 
Average 45.31± 15.42 [35.99, 54.63] 44.44 ± 15.53 [36.16, 52.71] 0.881 
Age    
<30yrs 53.00 ± 24.21 [38.37, 67.63] 45.33 ± 21.80 [33.72, 56.95] 0.936 
30-50yrs 52.33 ± 13.32 [44.29, 60.38] 48.33 ±  15.15 [40.26, 56.41] 0.711 
51-70yrs 39.00 ± 8.47 [33.88, 44.12] 40.71 ± 16.70 [31.82, 49.61]  0.813 
Etiology    
Diabetes Mellitus 38.33 ± 2.31 [36.94, 39.73] 41.0 ± 12.57 [34.30, 47.70] 0.735 
RTA 52.25 ± 15.31 [42.99, 61.50] 48.50 ± 15.29 [40.35, 56.65] 0.697 
Malignancy 22.00 65.00 N/A 
Others 34.0 [28.30, 39.70] 41.20 ± 19.45 [28.86, 53.54] 0.092 
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FIGURE 5.11 - RELATION OF GAIT VELOCITY WITH AGE AND ETIOLOGY OF RAS AND 
CONTROL GROUPS 
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5.8.2 GAIT CADENCE 
The average cadence was 92.46steps/min for patients in the RAS group and 96.38 
steps/min for patients in the control group. This difference was not found to be statistically 
significant, independent sample T test p value 0.319 
Gait cadence with respect to age and diagnosis is given in table 5.12 and figure 5.12 below 
TABLE 5.12 - CORRELATION OF GAIT CADENCE WITH AGE AND ETIOLOGY IN THE RAS AND 
CONTROL GROUPS 
 GAIT CADENCE (steps/min)  
 RAS 
Mean ± SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p 
value 
Average 92.46 ± 8.45 [87.35, 97.57] 96.38 ± 14.25 [88.78, 103.97] 0.391 
Age    
<30yrs 92.00 ± 38.30 [68.86, 115.15] 91.00 ± 41.56 [68.86, 113.14] 0.780 
30-50yrs 95.33 ± 5.03 [92.29, 98.38] 97.67 ± 17.22 [88.49, 106.84] 0.830 
51-70yrs 91.43 ± 9.57 [85.64, 97.21] 97.57 ± 13.46  [90.40, 104.75] 0.345 
Etiology    
Diabetes Mellitus 94.00 ± 12.49 [86.45, 101.55] 89.67 ± 12.61  [82.95, 96.39] 0.641 
RTA 93.75 ± 7.20 [89.40, 98.11] 99.50 ± 19.0 [89.38, 109.62] 0.453 
Malignancy 80.00 105.00 N/A 
Others 90.00 [74.92, 105.08] 100.20 ± 50.37 [73.36, 127.04] 
 
0.074 
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FIGURE 5.12 - RELATION OF GAIT CADENCE WITH AGE GROUP AND ETIOLOGY 
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5.8.3 STEP LENGTH 
The step length was tabulated in both normal and amputated sides, the values of which are 
mentioned below.  
TABLE 5.13 - CORRELATION OF STEP LENGTH OF BOTH AMPUTATED AND NORMAL SIDES IN 
RAS AND CONTROL GROUPS 
Step length(cm) RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p value  
Amputated side 38.92± 6.91 [34.75, 43.10] 49.06± 12.69 [42.30, 55.82] 0.016* 
Normal side 37.62± 11.08 [30.92, 44.31] 48.69± 12.53 [42.01, 55.36] 0.019* 
 
*pvalue<0.05 is considered statistically significant 
On comparing the intervention and control arms, the step length was lesser in the RAS 
group compared to control group in both amputated as well normal side and this difference 
was statistically significant (Independent sample T test p value 0.016 for the amputated 
side and 0.019 for the normal side). The step length between the amputated and normal 
side was also compared in both groups. Independent T test did not show any statistical 
significance with p values 0.72 and 0.93 for RAS and Control respectively. The difference 
in step length between the amputated and normal sides as a measure of symmetry is 
mentioned in the next section.  
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FIGURE 5.13 - STEP LENGTHS IN AMPUTATED AND NORMAL SIDES OF BOTH GROUPS 
 
5.8.4 SYMMETRY 
Symmetry of gait is a measure of step length of the affected and unaffected side. It is 
calculated using the following formula: 
𝑺𝒕𝒆𝒑 𝒍𝒆𝒏𝒈𝒕𝒉  𝒖𝒏𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅𝒍𝒊𝒎𝒃 –  𝑺𝒕𝒆𝒑 𝒍𝒆𝒏𝒈𝒕𝒉 (𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅𝒍𝒊𝒎𝒃)
𝑺𝒕𝒆𝒑𝒍𝒆𝒏𝒈𝒕𝒉 (𝒖𝒏𝒂𝒇𝒇𝒆𝒄𝒕𝒆𝒅𝒍𝒊𝒎𝒃)
 
The difference in step length between the unaffected and affected side was an average of 
1.3cm for the RAS group and 0.37cm for the control group. With the average step length 
of the unaffected side taken as 37.62 for the RAS group and 48.69 for the control group, 
the symmetry of gait was -0.03 for the RAS group which showed less symmetry than         
-0.01 of the control group.  
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5.8.5 STRIDE LENGTH 
Normalized stride length was compared. 
TABLE 5.14 - CORRELATION OF STRIDE LENGTH OF BOTH AMPUTATED AND NORMAL SIDES 
IN RAS AND CONTROL GROUPS 
Stride length(cm) RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD, 95% CI 
p 
value 
Amputated side 79.62 ± 13.14 [71.67, 87.55] 97.44 ± 29.64 [81.64, 113.23] 0.055 
Normal side 83.69 ± 0.17 [67.22, 100.17] 98.06 ± 27.26 [83.42, 112.70] 0.171 
 
Stride length was greater for those in the control group though there was no significant 
difference between the two groups. The IndependentT test also did not show a significant 
difference in stride length between the normal and affected sides in patients of RAS group 
(p value 0.63) or Control group (p value 0.95).  
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FIGURE 5.14 - STRIDE LENGTHS OF AMPUTATED AND NORMAL SIDES OF BOTH GROUPS 
 
5.8.6 STANCE SWING RATIO 
In one cycle of gait, the normal ratio of stance to swing is 60/40. The ratio of stance to 
swing in our patients is mentioned in the table below: 
TABLE 5.15 - STANCE SWING RATIO OF THE AMPUTATED AND NORMAL SIDES IN RAS AND 
CONTROL GROUPS 
Stance swing ratio RAS CONTROL 
Amputated side 71/29 70/30 
Normal side 74/26 74/26 
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5.8.7 SINGLE LIMB SUPPORT 
The percentage of support on one limb in a gait cycle (SLS) is mentioned in Table 5.16 
below 
TABLE 5.16 - SINGLE LIMB SUPPORT OF AMPUTATED AND NORMAL LIMBS IN RAS AND 
CONTROL GROUPS 
Single limb support (%) RAS 
Mean ±SD, 95% CI 
CONTROL 
Mean ±SD , 95% CI 
p 
value 
Amputated side 26.00 ±7.41 [21.53, 30.47] 26.00 ±6.84 [22.35, 29.65] 1 
Normal side 29.46 ±4.58 [26.70, 32.23] 29.88 ±5.93 [26.71, 33.04] 0.838 
 
In both groups, SLS was seen to be more on the normal side than on the amputated side.  
 
FIGURE 5.15 - PERCENTAGE OF SINGLE LIMB SUPPORT ON AMPUTATED AND NORMAL SIDE 
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5.8.8 ENERGY EFFICIENCY 
The PCI is used as an index of energy efficiency. Those in the intervention group had an 
energy efficiency of 0.86 and those in the control group had 0.82. Independent T test 
showed no significant difference in PCI between the two groups with p value 0.833 
5.8.9 KINETICS 
The average taken from the kinetic parameters of 9patients is according to the table below: 
TABLE 5.17 - KINETIC PARAMETERS OF GAIT  
 Kinetic Parameters  
 RAS ± SD 
 95% CI 
Control ± SD 
95 % CI 
p value 
Vertical force % 95.40 ± 15.04 
[86.31, 104.49] 
99.20 ± 11.56 
[93.04, 105.36] 
0.666 
Medial force % 0.20 ± 0.45 
 [-0.07, 0.47] 
1.60 ± 2.51 
 [0.26, 2.94] 
0.254 
Lateral force % 7.60 ± 3.58 
 [5.44, 9.76] 
7.40 ± 2.97  
[5.82, 8.98] 
0.926 
Forward force % 5.20 ± 3.78  
[2.92, 7.48] 
3.20 ± 2.28 
 [1.98, 4.42] 
0.340 
Backward force % 9.60 ± 3.44 
 [7.52, 11.68] 
7.00 ± 5.79 
 [3.92, 10.08] 
0.413 
 
There was no statistical significance between the kinetic parameters of the two groups 
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5.8.10 FREQUENCY OF RHYTHMIC BEATS USED 
13 patients in the RAS group underwent training using rhythmic auditory beats. The 
frequency varied from 25 beats per minute (bpm) to 120 bpm. A correlation of the 
frequency of beats used with the three primary outcome measures was analysed. We found 
that those who trained with lower frequency beats completed training at a significantly 
shorter time (p value 0.003) than those who trained with higher frequency beats. The 
6MWT was significantly better in those who trained with higher frequency beats (p value 
0.001). The TUG test was shorter in those who trained with higher frequency beats though 
it was not statistically significant.  It is summarised in table 5.18 below  
TABLE 5.18 - CORRELATION OF FREQUENCY OF BEATS USED TO PRIMARY OUTCOME 
MEASURES 
Beats used 
(bpm) 
No. of people 
(n) 
Hours to 
complete (hrs) 
Mean ±SD 
6MWT(m)  
Mean ± SD 
TUG(secs) 
Mean ± SD 
25 – 50 (lower 
frequency) 
8 (61.54%) 5.5 ± 2.98 280.91 ± 153.30 11.86 ± 6.19 
51 – 120 
(higher 
frequency) 
5 (38.46%) 7± 2.55 391.3 ± 118.05 9.86 ± 1.95 
p value  0.003* 0.001* 0.085 
 
*p value <0.05 is considered statistically significant 
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On analysing the data without the two skewed values (2 patients with malignancy), the 
TUG was found to be statistically significant in those who trained with higher frequency 
beats (p value 0.037) 
 
5.8.11 COMPARISON OF STUDY DATA TO NORMALIZED DATA 
The gait parameters attained in our study were compared to normalized data of a previous 
study done (10 normal subjects 5-15 years of age), the values of which are tabulated 
below: 
TABLE 5.19 - COMPARISON OF STUDY DATA WITH NORMAL DATA 
Gait parameter Study data Normal value 
 RAS  
Mean ± SD 
CONTROL 
Mean ± SD 
 
Mean ± SD 
Gait velocity (m/sec) 45.31 ± 15.42 44.44 ± 15.53 47 ± 15 
Stride length (cm) A:79.62±3.14 
N:83.69 ±7.26 
A:97.44 ± 29.64 
N:98.06 ± 27.47 
84 ± 8 
Stance swing ratio (%) A: 71/29 
N:74/26 
A:70/30 
N:74/26 
60/40 
Single Limb Support (%) A: 26.00 ±7.40 
N:29.46 ± 4.57 
A: 26.00 ± 6.84 
N: 29.88 ± 5.93 
40 ± 5 
PCI 0.86 0.82 0.5 ± 0.3 
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Gait parameter 
TABLE 5.19 (CONTINUED) 
Study data 
 
Normal value 
 RAS  
Mean ± SD 
CONTROL 
Mean ± SD 
 
Mean ± SD 
Kinetics    
Vertical force (%) 95.40 ± 15.40 99.20 ± 11.56 115 ± 19 
Medial force (%) 0.20 ± 0.45 1.60 ± 2.51 3 ± 2 
Lateral force (%) 7.60 ± 3.58 7.40 ± 2.97 5 ± 2 
Forward force (%) 5.20 ± 3.77 3.20 ± 2.28 17 ± 3 
Backward force (%) 9.60 ± 3.44 7.00 ± 5.79 18 ± 3 
 
A: Amputated side 
N: Normal side 
 
5.8.12 EXCLUSION OF TWO SKEWED VARIABLES 
Two patients with malignancies had deranged values which skewed the results. A sub-
analysis excluding these two patients showed statistically significant results in the outcome 
measures mentioned in table 5.20 
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TABLE 5.20 - ANALYSIS WITH EXCLUSION OF SKEWED VALUES 
 RAS 
Mean ± SD 
Control 
Mean ± SD 
p value 
Average TUG (s) 10.60 ± 1.97 13.64 ± 3.83 0.020* 
% decrease from 
regression to 
6MWT (%) 
45.99 ± 0.13 57.51 ± 0.14  0.038* 
Step length (cm) 
(Amputated side 
only) 
39.33 ± 7.05 48.27 ± 12.71 0.039* 
 
For patients in the RAS group, theprimary outcome measures depending on the frequency 
of beats used were as follows: 
RAS group 
Frequency of beats 
used (bpm) 
25 – 50 bpm 
Mean ± SD 
51 – 120 bpm 
Mean ± SD 
 
Hours to complete 
training (hrs) 
5.14 ± 2.73 7 ± 2.55 0.001* 
TUG (s) 11.13 ± 5.63 9.86 ± 1.95 0.037* 
6MWT(m) 301.83 ± 157.42 391.3 ± 118.05 0.001* 
*p value <0.05 is considered statistically significant 
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The average number of hours to complete prosthetic training reduced for those in the RAS 
group from 6.08 hours to 5.92 hours whereas it increased for those in the control group 
from 7.44 hours to 7.67 hours. This was however not statistically significant between the 
groups (p value 0.081). Gait velocity increased from 45.31 m/sec to 47.25 m/sec for those 
in the RAS group and it decreased from 44.44 m/sec to 43.07 m/sec for those in the control 
group. Independent T test did not show any statistical significance (p value 0.470).For 
patients in the RAS group, the gait parameters which improved in the sub-analysis were 
6MWT (323.37 m to 329.16 m),TUG test (11.09 s to 10.60 s), gait cadence (92.44 
steps/min to 93.70steps/min), stride length of both the amputated and normal sides and 
physiological cost index (0.86 to 0.79). Looking at all the same parameters in the sub-
analysis, patients in the control group had decreased walking distance in the 6MWT 
(288.96 m to 282.09 m), increased TUG time (13.43 s to 13.64 s), decreased cadence 
(96.38 steps/min to 95.80 steps/min), decreased stride length of both amputated and normal 
sides and increased physiological cost index (0.82 to 0.84).  
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TABLE 5.21 - ADDITIONAL ANALYSIS IN THE STUDY 
Observations RAS CONTROL Total/Mean 
Total no. of patients 
who developed ulcers 
(out of 44 patients) 
8 8 16 
No. of patients with 
ulcers who completed 
therapy  
2 5 7 
No. of patients with 
ulcers who walked 
without any ambulation 
aids 
1 (50%) 4 (80%) 5 (71.43%) 
No. of patients with 
ulcers who walked with 
quadripod / cane 
1 (50%) 1 (20%) 2 (28.57%) 
Etiology of patients 
with ulcers 
   
Diabetes Mellitus 
RTA 
Others 
1 
0 
1 
3 
2 
0 
4 
2 
1 
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 TABLE 5.21 (CONTINUED)  
Observations RAS CONTROL Total/Mean 
Amputation surgery 
performed 
   
Primary closure by 
posterior flap 
1 0 1 
Guillotine followed by 
secondary closure 
1 3 4 
No surgical details 0 2 2 
Average day of training 
when first ulcer 
occurred(day no.) 
2 3 2.5 
Age group most prone 
to develop ulcers 
(years) 
57 44 51 
Average no. of days lost 
due to ulcers(days) 
13.5 34.8 24 
Average no. of days to 
complete therapy 
including days lost due 
to ulcers(days) 
45 44.4 45 
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 TABLE 5.21 (CONTINUED)   
DROPOUTS RAS CONTROL Total/Mean 
Cause for dropouts    
Did not come for training 1 (50%) 1 (50%) 2  
Walking with walker 
(due to ulcer) 
5 (20.83%) 3 (15%) 8 (61.54%) 
Walking with axillary 
crutches (due to ulcer) 
1 (4.17%) 0 1 (7.69%) 
Discontinued training 4 (16.67%) 0 4 (30.77%) 
Total no. of dropouts 11 4 15 
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6 DISCUSSION 
The aim of the study was to evaluate the usefulness of Rhythmic Auditory Stimulation to 
enhance prosthetic training in persons with unilateral transtibial amputation as compared 
with conventional therapy.  
44patients were initially enrolled into our study and were randomised into two groups. 24 
patients were in the RAS group and 20 were in the control group. Of the 24 patients in the 
RAS group, 6 developed ulcers and could not complete training to achieve the required 
criteria. 3 patients of the 20 in the control group similarly could not achieve the required 
criteria due to ulcers. 4 patients in the RAS group dropped out before they could complete 
training. 1 patient from each group did not report for therapy and were considered drop 
outs. The final number of patients who completed training according to the defined criteria 
was 29 that is 13 in the intervention group who received rhythmic auditory stimulation 
during prosthetic training and 16 in the control group who followed the conventional 
method of training.  
The mean age of patients was 46 years in the intervention arm and 45 years in the control 
arm. The youngest patients were two 18 year old boys with left transtibial amputation due 
to road traffic accident. The oldest was a 65 year old man with right transtibial amputation 
due to infected diabetic foot. The most common age group for amputation was between 51 
– 70 years accounting for 48.28% of all amputees. This correlated with previous studies 
which reported increasing incidence of amputation in ages above 60, more commonly in 
males.(4)The most common cause of amputation in this age group was diabetic foot.  
   
 
86 
 
There was a total of 14 right transtibial and 15 left transtibial amputees. The most common 
cause of amputation we found in our group of patients was road traffic accidents which 
was the cause of 12 (41.38%) of the amputations. Diabetic foot due to Diabetes Mellitus 
which was the cause of amputation in 9 (31.03%) patients was the second most 
common.This confirmed previous data which recorded the leading cause of amputation in 
India to bedue to road traffic accidents followed by Diabetic foot.(4)Esquenazi et al. stated 
that trauma related accidents including motor vehicle, industrial or farming accidents were 
the leading cause of amputation in developing countries.(3)The other causes of amputation 
were malignancies (6.90%), Peripheral arterial occlusive disease, infection, bomb blast and 
vascular causes (20.69%). 
12 amputee patients started training within 6months after amputation, 13 patients started 
between 6months to 1 year and 4 patients started after 1 year. With delay in initiation of 
training after amputation, a minimal delay in time to completion was noticed in both 
groups. There was however a skewed value in the RAS group for a patient who began 
training after 1 year of amputation yet completed after 2 hours of therapy. This was 
attributed to the fact that the patient was a young 18 year old boy amputated secondary to 
trauma following a road traffic accident. Pohjolainenet al. stated that a time lag between 
surgical amputation and time to prosthetic training proved unfavourable for prosthetic 
usage.(76)They also reported poorer walking ability after 1year in those who waited longer 
to begin prosthetic training.  
13(44.83%)of the patients underwent primary posterior flap closure and 12 (41.38%) 
underwent guillotine amputations with secondary long posterior flap closure. 4 patients did 
not have any surgical details available. Guillotine amputation followed by secondary flap 
closure has been stated to be the most common method of surgical amputation as reported 
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in studies done by Allcock PA et al. (16) and Mooney et al(17). The major cause of 
amputation in our group of patientswas trauma related. Infection rates are higher in cases 
like diabetic foot than trauma related causes. 
The primary and secondary outcome measures were calculated using the independent 
sample T test. In our study, we found that patients in the RAS group completed training in 
6.08 hours and those in the control group in 7.44 hours. This difference however was not 
statistically significant with a p value of 0.159. Further studies with larger sample size may 
be helpful to see if there is any statistically significant difference between the two groups 
to complete training.  
Following conventional methods, the time to complete training has usually been an 
average of 2weeks or 14 days (1 hour each day making it approximately 14 hours therapy 
time). Our aim was to complete prosthetic training in 10 hours or less using RAS. The 
average time to complete therapy in both groups was found to be significantly less than the 
conventional time for completion (6.08 hours in the RAS group, 7.44 hours in the control 
group).  Currently we issue prosthetic training slips for a 14day period following which the 
patient is reviewed at the Amputee clinic for evaluation and permanent issuance of 
prosthetic limb. As we now see that the time frame for each individual differs, the practice 
of issuing therapy slips for a fixed period of 14days can be altered. The patient can resume 
work and return to their lives and families at the earliest. This would also be of economic 
benefit to the patient as he would not have to pay for extra therapy time which he may not 
need. Also, as a bulk of our patients come from outside the state, this would be 
economically beneficial to them as extra days of accommodation and rent would be 
avoided.  
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Davies and Datta in 2003stated that chances of prosthetic mobility decreased with 
increasing age.(31)Scremin et al. in their study stated that the rate of healing was directly 
proportional to age and hence related to progress in using the temporary 
prosthesis.(32)Pohjolainen et al. in their study (76)reported that increasing age had an 
unfavourable association with walking distance, walking time, amount of outdoor mobility 
and use of aids. In our study, correlation could be made only for those >50 years of age 
who were seen to have decreased walking distance and decreased walking speed compared 
to the younger age group. Advancing age did not seem to have a negative effect in any of 
the other parameters. 
Time to completion analysed with diagnosis was not statistically significant in either of the 
groups. A few studies such as those done by Geertzen et al. (77), Davies and Datta(31) 
reported decreased outcome mobility scores in amputation due to vascular causes as 
opposed to traumatic or other causes. Munin MC et al (78) Johnson V J et al(79) clearly 
stated that the etiology of amputation had no influence on mobility. In our study, no 
significance was derived from etiology in relation to time for completion or any of the 
primary outcome measures or gait parameters. One 22 year old girl had undergone 
amputation secondary to a right calcaneal giant cell tumour. With prosthetic training in the 
control group, she successfully completed training in 4 hours. She did exceptionally well 
and had good gait parameters. The other patient with malignancy was a 28 year old man 
with recurrent synovial sarcoma of the left leg who 6 months after the last adjuvant 
chemotherapy was found to have lung metastasis. This was diagnosed only after recruiting 
the patient and after training had started. After recruitment into the RAS group, he did well 
at the start of therapy but on knowing about the prognosis, lost motivation and was unable 
to walk independently. He completed training in 8 hours, walking with a quadripod.  
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We did not derive any significant difference between the time to completion nor the gait 
parameters of those with Diabetes Mellitus and those who underwent traumatic amputation 
secondary to road traffic accidents. There was only one patient with amputation due to 
vascular causes who was part of the study. He was in the control group and completed 
training in 7 hours. The significance of this cannot be commented on in this study.  
Another primary outcome measure was the timed up and go (TUG) test. Patients in the 
RAS group were seen to complete the TUG test in a shorter time of 11.09seconds. Those in 
the control group took 13.43seconds. This was however not statistically significant (p 
value 0.069). Age and diagnosis analysis in relation to TUG test showed shorter TUG time 
in the RAS group in all categories when compared with control group except forone patient 
with malignancy in the RAS group who took 16.99seconds as opposed to the patient with 
malignancy in the control group who took 10seconds. We did a sub-analysis which 
excluded the two patients with malignancy and found that the TUG test became 
statistically significant (p value 0.020). With this, we inferred that RAS could possibly be 
useful for improving functional mobility in the transtibial amputee patient. The usefulness 
of the TUG test as stated by Dite et al. 2007(72)was to predict the risk of falls and 
functional mobility outcome in community dwelling individuals the cut off score being 
13.5s (73).  
The 6-minute walking test (6MWT) was another predictor of community independence 
and ambulation. In our group of patients, we found that those in the RAS group walked an 
average of 323.37m while those in the control group covered 288.96m in 6minutes (p 
value0.390). This value though not seen to be statistically significant between the two 
groups showed that both groups of patients reached the required limit of 132m to 342m in 
order to be independent community ambulators as stated by C.Robinett et al.(75)The 
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average 6MWT in all age groups was more in the RAS group than control group though 
none were found statistically significant. Analysis of age and etiology to 6MWT did not 
show any significant result. As stated earlier, only those >50 years had shorter walking 
endurance than those <50 years of age. In a study reported by Davies and Datta, almost all 
unilateral transtibial amputees less than 50 years of age attained community mobility 
whereas only 50% of those more than 50 years of age attained community mobility(31) 
which correlated with our study.  
The calculated percentage decrease from the formulated regression equation to the 6MWT 
of our patients was48.61% for the RAS group and 57.02% for the control group. This 
significant drop in the 6 minute walking endurance in our patients as compared to normal 
individualsmay be explained by the hypothesis made by Suh-Jen lin et al.(74)who stated 
that impaired prosthetic balance and shorter walking endurance may be due to the decrease 
in muscle strength in addition to loss of voluntary ankle movement. Between the groups, 
the difference was not statistically significant (p value 0.134). However, on sub-analysis 
and exclusion of the two skewed values, this too became statistically significant with a 
percentage decrease from regression to 6MWT of 45.99% in the RAS group and 57.51% in 
the control group (p value 0.038).  
Gait parameters were calculated for both groups. There was no statistical significance in 
the gait velocity and cadence between the two groups (p value 0.881, 0.391 respectively). 
In both groups, patients between 30 – 50 years of age had better cadence. It was however 
found that average gait cadence of those in the control group was more than those in the 
RAS group.We attributed this to the fact that following external cueing could bring about a 
systematic or forced slowing of gaitbringing about a decrease in the number of steps taken. 
It is possible that using higher frequency beats can overcome this setback.  
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There was no statistical significance in relation of velocity to cause of amputation. This 
correlates with earlier reports which state no significant difference in gait velocities 
depending on etiology of amputation.(80)Similarly, patients in the control group had 
significantly greater step length than those in the RAS group (p value 0.016 on the 
amputated side and 0.019 on the normal side). The stride length of the amputated side was 
also significantly greater (p value 0.055) in the control group. This was also hypothesized 
to be for the same reason of external cueing causing a forced reduction in step length and 
stride length in the RAS group.  
Other gait parameters such as symmetry of gait, stance swing ratio and single limb support 
did not show any statistical significance between the two groups. On comparing the normal 
with the amputated sides, the single limb support was found to be more on the normal side 
than the amputated side in both groups. In the normal gait cycle, stance occupies 60 – 62% 
and swing occupies38 - 40% of the cycle. According to literature the prolonged duration of 
stance on the normal side, seen in our group of patients can be attributed to the loss of 
ankle plantar flexion in the prosthetic foot of amputee patients causing early toe off in the 
amputated limb.(81) 
A pilot study was done on 10 children over a 4 month period in the motion analysis 
lab,CMC (1998) from which we attained our normalized data. On comparing our data to 
the normal values, we found that most of the parameters were compatible with the 
normalized data except for single limb support and stance swing ratio. This only partially 
coincided with earlier studies done by Robinson et al 1977;Levine1984; Saleh and 
Murdoch 1985 who reported thatamputees have a significantly lower walking speed as 
compared to normal individuals. 
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The symmetry in gait which is a measure of step lengths of the affected and unaffected side 
was not seen to be significantly different in either group.  
Physiological cost index was found to have increased but still remained within normal 
limits for both groups without statistical significance between the two groups (p value 
0.833).  This confirmed the reports of YahyaSet al. who stated that physiological weight 
bearing and hence metabolic energy consumption was more in those with below knee 
amputees than in normal subjects.(82) 
The kinetic parameters when calculated showed a significant decrease in forward and 
backward forces when compared to normalized values. This was in partial agreement with 
earlier studies done by Suzuki 1972; Seliktar and Mizrahi 1986; Hurley et al. 1990 where a 
decrease in ground reaction forces was seen in unilateral below knee amputations. The 
difference in gait parameters between the two groups was not statistically significant. 
The relation of frequency of beats used to primary outcome measures was derived. Those 
who underwent training with lower frequency beats (25 – 50 bpm) were seen to have a 
significantly quicker time to completion of training (p value 0.003). However, those who 
used higher frequency beats(51 – 120 bpm) had significantly better outcomes in 6MWT (p 
value 0.001) and also showed better TUGresults(p value 0.085) when compared to lower 
frequency beats.We believe that higher frequency beats can lead to increased cadence and 
hence longer distance covered. However, there are more chances of forced cueing and step 
and stride length reduction. To overcome this, starting with low frequency beats which are 
comfortable to the patient and progressively increasing it to the patients‟ threshold while 
all the time maintaining symmetry would be the ideal method of training.   
There were various factors which hindered therapy and delayed time to completion in 
many patients. One such factor was the propensity of ulcer development in most new 
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prosthetic limb users. This was found to hinder therapy on a large scale as the patient had 
to avoid bearing weight on the ulcerated residual limb. In our patients, therapy was 
resumed only after the ulcer had completely healed. 
The type of surgery performed and the development of ulcers was not found to be 
significantly related.  Ulcers were found to form most commonly on the 2
nd
 day after 
prosthetic training. The patients who developed ulcers lost an average of 24 days before 
they could resume training. 
The causes of ulceration were narrowed down to the following reasons: 
Ill-fittingprosthesis: Inadequate pressure relief on weight bearing points of the residual 
limb caused ulcers to develop over those areas. Using silicone sleeves were found to 
minimize shear forces and decrease recurrent skin lesions.(83) Socket modification helped 
reduce the pressure points.  
Type of skin: As the skin and soft tissues of the residual limb are not as thick as that of 
the palms and soles, it can break down easily with shear forces and extra pressure. The rate 
of ulcer development was found to be directly proportional to the type of skin on the 
residual limb,  
Low nutritional status:  The normal BMI for the Indian population is within 18.5 – 
22.9.(84)Majority of the patients (37.93%) had their BMI within normal range. 34.48% 
were underweight, 20.69% were obese and 6.9% were overweight. In our study, 4 patients 
(57.14%) of those who developed ulcers had their BMI within 18.5 – 22.9 and were within 
normal range. 2 patients (28.57%) were underweight and 1 patient was obese. As the BMI 
is a measure of nutritional status, this outcome did not support previous studies of 
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Berrdigeet al.whoin their analysis concluded that low nutritional status plays an important 
role in ulcer development.(22) 
Wound breakdown: Primary wound healing is defined as healing of the surgical scar 
within the fourteenth post-surgical day. 50% of below knee amputees have failure of 
primary wound healing. Breakdown of scar following this period is termed as secondary 
wound breakdown.(85) The frequency of wound breakdown was found to depend on the 
location of the scar line and the protocol of wound management followed postoperatively.   
Age: In our group of patients the average age group of 51 years was seen to be most prone 
to ulcers. This may be due to decreased nutritional status, decreased general condition, 
friability of skin, in addition to other factors which may cause increased chances of 
ulceration with increasing age.  
Etiology of amputation: 57.14% of those with ulcers had undergone amputation due to 
diabetic foot. Such patients may have compromised peripheral vasculature leading to 
increased chances of ulcer formation. 
Inadequate limb hygiene and care of stump leading to increased chances of ulcer 
formation. 
The current clinical practice we follow for patients who develop pressure ulcers is to 
temporarily stop therapy for as long as the ulcer lasts.  A study was done in 2006 by 
Salawu A etal.on 102 patients with prosthetic limb ulcers to associate the size of the ulcer 
with continued prosthetic use. It was found that despite prosthetic use, 64% ulcers healed 
completely and 25% ulcers decreased in size.(83) Temporary discontinuation of training 
due to pressure ulcers can limit activity and delay completion and patients‟ return to work. 
In our study, the average number of days to complete training including the days lost due 
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to ulcer formation was 45 days. Socket modification with relieving forces may enable the 
ulcers to heal while allowing continued use of the prosthesis. This is important to note as 
the time taken to complete therapy and the patients‟ return to home and work can be 
significantly decreased by following the current international protocol of not discontinuing 
prosthetic training when ulcers are present. This however cannot be generalized. The stage 
of the ulcer up to which weight bearing can be considered needs to be further evaluated 
and can be a topic of further research.  
Last but not the least, motivation, will power and positive attitude goes a long way in 
helping a patient ambulate. We observed that many of our patients who did well were 
optimistic and motivated. Following age, this seemed to be the next strong factor 
determining time to completion as well as quality of gait. However, in our study wedid not 
have any questionnaires which objectively measured the relation between motivation levels 
and time to completion. This could be considered for further research.  
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7 CONCLUSION 
 
1. Patients who received prosthetic training enhanced by rhythmic auditory 
stimulation(RAS) completed training faster than those who underwent the training 
without RAS though this difference was not  statistically significant.(p= 0.159). 
Use of RAS for prosthetic training may be helpful to reduce the training time and 
thereby the cost of treatment. 
2. The other two primary outcome measures, the Timed Up and Go (TUG) test and 6 
minute walk test (6MWT) also showed favourable results for patients under the 
RAS group more than for those in the control group though no statistical 
significance could be derived.  RAS may potentially improve walking endurance 
and enable independent community ambulation for unilateral transtibial amputee 
patients. Larger studies with long term follow-up and community independence 
based questionnaires can be considered for future research 
3. Step length was found to be significantly better for those in the control group 
(p=0.016 on amputated side and 0.019 on normal side) probably because of 
external cueing possibly leading to “forced gait” in RAS patients. The other gait 
parameters measured did not show any statistical significance between the two 
groups. Within the small sample size studied, RAS enhanced therapy could not 
demonstrate better gait parameters in transtibial amputee patients.  
   
 
97 
 
4. On doing a sub-analysis excluding two skewed values, one from each group, 
statistical significance was found in the TUG test (p=0.02)and percentage decrease 
from regression to 6 minute walk test (p=0.038) as well.   
5. Patients in the RAS group were found to finish training in a significantly shorter 
time when they used slower frequency beats (p=0.003). However 6MWT of 
statistical significance (p=0.001) and better TUG(p=0.085) was seen with the use of 
higher frequency beats. Further studies with larger samples may be required to 
establish this correlation. 
6. Drop outs were mostly due to development of non-healing ulcers over the residual 
limb, leading to loss of several days of prosthetic training. This could be avoided by 
continuing weight bearing and gait training even in the presence of ulcers, as per 
the international protocols, along with prosthetic alteration and use of silicone 
liners.  
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8 LIMITATIONS OF THE STUDY 
1. The sample size was small. The number required for statistical significance at a CI 
of 95% could not be achieved in the intervention arm. 
 
2. There were a large number of dropouts the majority being due to non-healing ulcers 
present in the residual limbs. This caused pain and restricted ambulation and 
limited further progress in training. 
 
3. Instrumental gait analysis could be completed only for 9 patients due to unresolved 
technical problems in the motion analysis lab. 
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9 SCOPE FOR FUTURE RESEARCH 
1. A similar study with a larger sample size may show statistically significant results 
on time to completion, walking endurance and gait parameters. 
 
2. EMG studies can be added to localize the activation of muscles and effect of ankle 
plantar flexion loss in the prosthetic foot causing gait changes in amputee patients.  
 
3. Long term effects of rhythmic auditory stimulation can be analysed by introducing 
home based walking programmes. Level of independence and ambulation in the 
community can subsequently be assessed.  
 
4. The effect of continuing prosthetic training with ulcers can be further researched. A 
proper guideline for continuing training with the presence of ulcer can be 
formulated.  
 
5. Further studies can include questionnaires which address the effect of motivation 
and will power in patients who undergo training.  
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11 ANNEXURE 
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2. Patient Information sheet and consent form 
3. Information brochure 
4. Rivermead mobility Index 
5. Database with the main results 
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PATIENT INFORMATION SHEET 
Christian Medical College, Vellore 
Department of PMR 
 
A randomized controlled trial of rhythmic auditory stimulation for gait training in 
unilateral amputee patients 
Principle Investigator- Dr. Lahunlang Millian Sohliya 
Christian Medical College, Vellore 
 
Introduction 
I am Dr. Lahunlang Sohliya, working for The Department of Physical Medicine and 
Rehabilitation, Christian Medical College and Hospital. We are doing research on 
Unilateral Transtibial Amputee patients, using rhythmic auditory simulation. I am going to 
give you information and invite you to be part of this research. Before you decide, you can 
talk to anyone you feel comfortable with about the research. 
What is the purpose of the research? 
Patients who have amputated limbs come to us to learn how to walk with prosthesis. We 
train them until they can walk by themselves. Rhythmic Auditory Stimulation is a new 
method which we want to use for training amputee patients to walk with their prosthesis. 
The reason why we are doing this research is to find out if a patient can complete training 
in a shorter period of time and if the walking abilities with a new prosthesis are better than 
the method currently being used.  
   
 
110 
 
If you take part what will you have to do? 
This research will involve audio beats which you will need to follow as you train to walk. 
Your training will continue until you are able to walk on your own, without any support. 
When you are able to do so, some tests will be done at a gait lab, to assess your gait and 
the effect of the training you had.  
Participant selection 
We are inviting all unilateral transtibial amputee patients within the age of 15-60 years, 
who will be attending the Amputee clinic at PMR, to participate in the research of RAS. 
Can you withdraw from this study after it starts? 
Your participation in this research is entirely voluntary. It is your choice whether to 
participate or not. After the study has started, you still have the liberty to withdraw out of 
it. Whether you choose to participate or not, all the services you receive at this clinic will 
continue and nothing will change. If you choose not to participate in this research project, 
you will be offered the treatment that is routinely offered in hospital for prosthetic training. 
What will happen if you develop any study related injury? 
We do not expect any injury to happen, but if any unexpected problems occur due to the 
study, these will be treated at no cost for you. We will however not be able to provide any 
monetary support. 
What will you have to pay for the study? 
You will not need to pay for any tests which will be done for you at the end of the study. 
Paying for the training exercises and prosthesis however will be according to the usual 
protocol and concession will be given in case you are unable to pay the full amount. 
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What happens after the study is over? 
This study may or may not have helped you complete training faster than the usual 
training. You will however be expected to walk independantly with your prosthesis at the 
end of the study. 
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not be 
identified by name in any publication or presentation of results. However, your medical 
notes may be reviewed by people associated with the study, without your additional 
permission, should you decide to participate in this study. 
If you have any further questions, please ask Dr.Lahunlang Sohliya or Dr. Raji 
Thomas (tel: 0416-2282158/ 8940068106) or email: lahunlang@cmcvellore.ac.in 
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CONSENT TO TAKE PART IN A CLINICAL TRIAL 
 
Study Title:A randomized controlled trial of rhythmic auditory stimulation for gait 
training in unilateral amputee patients 
 
Study Number: 
Participant’s name: 
Date of Birth / Age (in years): 
 
I_____________________________________________________________ 
___________, son/daughter of  ___________________________________ 
 
(Please tick boxes) 
Declare that I have read the information sheet provide to me regarding this study and have 
clarified any doubts that I had. [ ] 
I understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting my usual 
treatment or my legal rights [ ] 
I understand that neither I, nor my doctors, will have any choice or knowledge of whether I 
will be in the experimental group with beats or the other group withoutbeats[ ]  
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I understand that I will receive free treatment for any study related injury or adverse event 
but I will not receive and other financial compensation [ ] 
I understand that the study staff and institutional ethics committee members will not need 
my permission to look at my health records even if I withdraw from the trial. I agree to this 
access [ ]  
I understand that my identity will not be revealed in any information released to third 
parties or published [ ]  
I voluntarily agree to take part in this study [ ] 
 
Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
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INVESTIGATORS‟ BROCHURE 
Age  
Height  
Weight  
Smoking(Y/N)  
Dominant/ Non dominant limb  
Length of residual limb  
Stump Edema  
Phantom pain/ neuroma  
Hearing(Normal/Slight impairment) - Weber‟s 
&Rinne‟s test 
 
Sight(Normal/Slight impairment)  
Comorbidities(Y/N)  
 
 
Patient no.  
Patient Name  
Hospital no.  
Diagnosis  
Cause of amputation 
 
Date of amputation 
 
Date since patient last 
walked 
 
Date: /          /201 Day no.  Time AM/PM 
Starting Frequency of 
beats 
 Frequency of beats used  
Steps achieved 
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RESULTS DEMOGRAPHIC DATA 
No. of hours 
for gait 
training (hrs) 
RAS Control p value AGE (yrs) RAS Control Total 
Average 6.08 7.44 0.159 
Mean age(18-
70) 
46 45 45 
<30yrs 5 5 0.722 <30 3 3 6 
30-50yrs 7 8 0.831 % 
10.34
% 
10.34% 
20.69
% 
51-70yrs 6 8 0.089 30-50 3 6 9 
    
% 
10.34
% 
20.69% 
31.03
% 
Gait velocity 
(m/min) 
RAS CONTROL 
 
51-70 7 7 14 
Average 45.31 44.44 0.881 % 
24.14
% 
24.14% 
48.28
% 
<30yrs 53.00 45.33 0.936 
    
31-50yrs 52.33 48.33 0.711 SEX RAS Control 
 
51-70yrs 39.00 40.71 0.813 Males 13 13 26 
Diabetes Mellitus 38.33 41.00 0.735 Females 0 3 3 
RTA 52.25 48.50 0.697 Males % 
44.83
% 
44.83% 
89.66
% 
Malignancy 22.00 65.00 N/A Females % 0.00% 10.34% 
10.34
% 
Others 34.00 41.20 0.092 
 
RAS Control 
 
    
Average 
Height 
169 172 
 
Gait 
cadence(steps/min) 
RAS CONTROL 
  
RAS Control 
 
Average 92.46 96.38 0.391 
Average 
Weight 
62 60 
 
<30yrs 92.00 91.00 0.780 
    
30-50yrs 95.33 97.67 0.830 
SIDE OF 
AMPUTATIO
N 
RAS Control 
 
51-70yrs 91.43 97.57 0.345 
Right 
transtibial 
8 6 
 
Diabetes Mellitus 94.00 89.67 0.641 % 
27.59
% 
20.69% 
 
RTA 93.75 99.50 0.453 
Left 
transtibial 
5 10 
 
Malignancy 80.00 105.00 N/A % 
17.24
% 
34.48% 
 
Others 90.00 100.20 0.074 
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ETIOLOGY RAS Control Total 
Step length(cm) RAS CONTROL 
 
Diabetes 
Mellitus 
3 6 9 
Amputated side 38.92 49.06 0.016 % 
10.34
% 
20.69% 
31.03
% 
Normal side 37.62 48.69 0.019 <30years 0 0 0 
p value 0.72 0.93 
 
30-50 years 1 3 4 
    
> 50 years 2 3 5 
Stride length(cm) RAS CONTROL 
 
With ulcer 1 3 4 
Amputated side 79.62 97.44 0.055 % 
14.29
% 
42.86% 
57.14
% 
Normal side 83.69 98.06 0.171 
    
p value 0.63 0.95 
 
RTA 8 4 12 
    
% 
27.59
% 
13.79% 
41.38
% 
Symmetry RAS CONTROL 
 
<30 years 2 2 4 
Average -0.03 -0.01 
 
30-50 years 2 2 4 
    
> 50 years 4 0 4 
Stance swing ratio RAS CONTROL 
 
With ulcer 0 2 2 
Amputated side 71/29 70/30 
 
% 0.00% 28.57% 
28.57
% 
Normal side 74/26 74/26 
     
    
Malignancy 1 1 2 
Single limb support 
(%) 
RAS CONTROL 
 
% 3.45% 3.45% 6.90% 
Amputated side 26.00 26.00 1 <30years 1 1 2 
Normal side 29.46 29.88 0.838 30-50 years 0 0 0 
    
>50 years 0 0 0 
PCI RAS CONTROL 
 
With ulcer 0 0 0 
Average 0.86 0.82 0.833765 % 0.00% 0.00% 0.00% 
        
Complete gait 
analysis 
RAS CONTROL 
 
Others 1 5 6 
Vertical Force % 95.40 99.20 0.666 % 3.45% 17.24% 
20.69
% 
Medial Force % 0.20 1.60 0.254 <30 years 0 0 0 
Lateral Force % 7.60 7.40 0.926 30-50 years 0 1 1 
Forward Force % 5.20 3.20 0.340 > 50 years 1 4 5 
Backward Force % 9.60 7.00 0.413 
    
TUG in secs RAS CONTROL P value 
Average 11.09 13.43 0.069 
<30years 11.12333 14.23333 0.570 
30-50 11.23 12.09 0.576 
51-70 11.02 14.24 0.068 
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Diabetes Mellitus 10.34 13.84 0.083 
RTA 10.47 13.38 0.218 
Malignancy 16.99 10.37 N/A 
Others 12.42 13.60 0.087 
  
  
6MWT in meters RAS CONTROL  
Average 323.3692 288.96 0.390 
<30years 364.1733 312.09 0.934 
30-50 401.17 325.43 0.268 
51-70 272.54 247.80 0.570 
Diabetes Mellitus 373.33 246.03 0.092 
RTA 339.69 346.57 0.919 
Malignancy 134.52 392.00 N/A 
Others 231.78 273.80 0.081 
25-50 bpm RAS CONTROL 
 
No.of people 8  
 
No.of people (%) 61.54% 
 
 
Mean age 48 
 
 
Average of hours 5.5  0.003 
Average TUG in secs 11.86125  0.085 
Average 6MWT in meters 280.9125  0.001 
51-120bpm RAS CONTROL 
 
No.of people 5 
 
 
No.of people (%) 38.46% 
 
 
Mean age 42 
 
 
Average of hours 7 
 
 
Average TUG in secs 9.862 
 
 
Average 6MWT in meters 391.3 
 
 
 
